Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

CD Marsden

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Living Beings

Chemicals & Drugs

Anatomy

Procedures

Electromyography

Activities & Behaviors

Concepts & Ideas

Time Factors

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
354
Jenner, Peter
151
Rothwell, John
121
Quinn, Niall
49
Day, Brian
41
Lees, Andrew
39
Brooks, David
36
Obeso, Jose
29
Brown, Peter
28
Bhatia, Kailash
27
Lang, Anthony
26
Harding, AE
24
Daniel, Susan
23
Dexter, David
23
Brown, Richard
20
Wood, Nicholas

Sign-in to see all Coauthors

Publications

TOP 3
Anderson Tim; Luxon Linda; Quinn Niall; Daniel Susan; Marsden C David; Bronstein Adolfo
Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients.
McAuley J H; Corcos D M; Rothwell J C; Quinn N P; Marsden C D
Levodopa reversible loss of the Piper frequency oscillation component in Parkinson's disease.
Schrag A; Münchau A; Bhatia K P; Quinn N P; Marsden C D
Essential tremor: an overdiagnosed condition?

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of CD Marsden (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Anderson Tim; Luxon Linda; Quinn Niall; Daniel Susan; Marsden C David; Bronstein Adolfo
Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients.
Movement disorders : official journal of the Movement Disorder Society 2008;23(7):977-84.
2001: McAuley J H; Corcos D M; Rothwell J C; Quinn N P; Marsden C D
Levodopa reversible loss of the Piper frequency oscillation component in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2001;70(4):471-6.
2000: Schrag A; Münchau A; Bhatia K P; Quinn N P; Marsden C D
Essential tremor: an overdiagnosed condition?
Journal of neurology 2000;247(12):955-9.
2000: Münchau A; Mathen D; Cox T; Quinn N P; Marsden C D; Bhatia K P
Unilateral lesions of the globus pallidus: report of four patients presenting with focal or segmental dystonia.
Journal of neurology, neurosurgery, and psychiatry 2000;69(4):494-8.
2000: Dressler D; Dirnberger G; Bhatia K P; Irmer A; Quinn N P; Bigalke H; Marsden C D
Botulinum toxin antibody testing: comparison between the mouse protection assay and the mouse lethality assay.
Movement disorders : official journal of the Movement Disorder Society 2000;15(5):973-6.
2000: McAuley J H; Marsden C D
Physiological and pathological tremors and rhythmic central motor control.
Brain : a journal of neurology 2000;123 ( Pt 8)():1545-67.
2000: Jarman P R; Bhatia K P; Davie C; Heales S J; Turjanski N; Taylor-Robinson S D; Marsden C D; Wood N W
Paroxysmal dystonic choreoathetosis: clinical features and investigation of pathophysiology in a large family.
Movement disorders : official journal of the Movement Disorder Society 2000;15(4):648-57.
2000: Leiguarda R; Merello M; Balej J; Starkstein S; Nogues M; Marsden C D
Disruption of spatial organization and interjoint coordination in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.
Movement disorders : official journal of the Movement Disorder Society 2000;15(4):627-40.
2000: Brundin P; Pogarell O; Hagell P; Piccini P; Widner H; Schrag A; Kupsch A; Crabb L; Odin P; Gustavii B; Björklund A; Brooks D J; Marsden C D; Oertel W H; Quinn N P; Rehncrona S; Lindvall O
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease.
Brain : a journal of neurology 2000;123 ( Pt 7)():1380-90.
2000: Leiguarda R C; Marsden C D
Limb apraxias: higher-order disorders of sensorimotor integration.
Brain : a journal of neurology 2000;123 ( Pt 5)():860-79.
2000: Lee M S; Rinne J O; Marsden C D
The pedunculopontine nucleus: its role in the genesis of movement disorders.
Yonsei medical journal 2000;41(2):167-84.
2000: Schrag A; Quinn N P; Bhatia K P; Marsden C D
Benign hereditary chorea--entity or syndrome?
Movement disorders : official journal of the Movement Disorder Society 2000;15(2):280-8.
2000: McAuley J H; Britton T C; Rothwell J C; Findley L J; Marsden C D
The timing of primary orthostatic tremor bursts has a task-specific plasticity.
Brain : a journal of neurology 2000;123 ( Pt 2)():254-66.
2000: Bandmann O; Vaughan J R; Holmans P; Marsden C D; Wood N W
Detailed genotyping demonstrates association between the slow acetylator genotype for N-acetyltransferase 2 (NAT2) and familial Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2000;15(1):30-5.
2000: Bhatia K P; Lee M S; Rinne J O; Revesz T; Scaravilli F; Davies L; Marsden C D
Corticobasal degeneration look-alikes.
Advances in neurology 2000;82():169-82.
1999: Pramstaller P P; Salerno A; Bhatia K P; Prugger M; Marsden C D
Primary central nervous system lymphoma presenting with a parkinsonian syndrome of pure akinesia.
Journal of neurology 1999;246(10):934-8.
1999: Schrag A; Samuel M; Caputo E; Scaravilli T; Troyer M; Marsden C D; Thomas D G; Lees A J; Brooks D J; Quinn N P
Unilateral pallidotomy for Parkinson's disease: results after more than 1 year.
Journal of neurology, neurosurgery, and psychiatry 1999;67(4):511-7.
1999: Schrag A; Bhatia K P; Quinn N P; Marsden C D
The dancing larynx--a variant of palatal tremor?
Movement disorders : official journal of the Movement Disorder Society 1999;14(5):882-3.
1999: Mathen D; Marsden C D; Bhatia K P
SSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystonia.
Movement disorders : official journal of the Movement Disorder Society 1999;14(5):874-6.
1999: Bateman D E; Levett K; Marsden C D
Sleep benefit in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1999;67(3):384-5.
1999: Rossor M N; Tyrrell P J; Warrington E K; Thompson P D; Marsden C D; Lantos P
Progressive frontal gait disturbance with atypical Alzheimer's disease and corticobasal degeneration.
Journal of neurology, neurosurgery, and psychiatry 1999;67(3):345-52.
1999: Brown P; Marsden C D
The stiff man and stiff man plus syndromes.
Journal of neurology 1999;246(8):648-52.
1999: Bhatia K P; Münchau A; Thompson P D; Houser M; Chauhan V S; Hutchinson M; Shapira A H; Marsden C D
Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases.
Journal of neurology, neurosurgery, and psychiatry 1999;67(1):90-3.
1999: Hagell P; Schrag A; Piccini P; Jahanshahi M; Brown R; Rehncrona S; Widner H; Brundin P; Rothwell J C; Odin P; Wenning G K; Morrish P; Gustavii B; Björklund A; Brooks D J; Marsden C D; Quinn N P; Lindvall O
Sequential bilateral transplantation in Parkinson's disease: effects of the second graft.
Brain : a journal of neurology 1999;122 ( Pt 6)():1121-32.
1999: Schrag A; Bhatia K; Brown P; Marsden C D
An unusual jaw tremor with characteristics of primary orthostatic tremor.
Movement disorders : official journal of the Movement Disorder Society 1999;14(3):528-30.
1999: Schrag A; Bhatia K P; Quinn N P; Marsden C D
Atypical and typical cranial dystonia following dental procedures.
Movement disorders : official journal of the Movement Disorder Society 1999;14(3):492-6.
1999: Brown P; Marsden C D
Bradykinesia and impairment of EEG desynchronization in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1999;14(3):423-9.
1999: Schrag A; Muenchau A; Bhatia K P; Quinn N P; Marsden C D
Overdiagnosis of essential tremor.
Lancet 1999;353(9163):1498-9.
1999: Werring D J; Marsden C D
Visual hallucinations and palinopsia due to an occipital lobe tuberculoma.
Journal of neurology, neurosurgery, and psychiatry 1999;66(5):684.
1999: Wills A J; Brusa L; Wang H C; Brown P; Marsden C D
Levodopa may improve orthostatic tremor: case report and trial of treatment.
Journal of neurology, neurosurgery, and psychiatry 1999;66(5):681-4.
1999: Soonawala N; Bhatia K P; Yeung J H; Quinn N P; Marsden C D
Idiopathic blepharospasm does not lead to a parkinsonian syndrome: results of a questionnaire-based follow-up study.
Journal of neurology 1999;246(4):283-6.
1999: Kingsbury A E; Marsden C D; Foster O J
The vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis: an in situ hybridization study.
Movement disorders : official journal of the Movement Disorder Society 1999;14(2):206-18.
1999: Riedl A G; Watts P M; Edwards R J; Schulz-Utermoehl T; Boobis A R; Jenner P; Marsden C D
Expression and localisation of CYP2D enzymes in rat basal ganglia.
Brain research 1999;822(1-2):175-91.
1999: McAuley J H; Farmer S F; Rothwell J C; Marsden C D
Common 3 and 10 Hz oscillations modulate human eye and finger movements while they simultaneously track a visual target.
The Journal of physiology 1999;515 ( Pt 3)():905-17.
1999: Houser M K; Soland V L; Bhatia K P; Quinn N P; Marsden C D
Paroxysmal kinesigenic choreoathetosis: a report of 26 patients.
Journal of neurology 1999;246(2):120-6.
1999: Pearce R K; Jackson M; Britton D R; Shiosaki K; Jenner P; Marsden C D
Actions of the D1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosets.
Psychopharmacology 1999;142(1):51-60.
1999: Pearce R K; Costa S; Jenner P; Marsden C D
Chronic supranigral infusion of BDNF in normal and MPTP-treated common marmosets.
Journal of neural transmission (Vienna, Austria : 1996) 1999;106(7-8):663-83.
1999: McAuley J H; Rothwell J C; Marsden C D
Human anticipatory eye movements may reflect rhythmic central nervous activity.
Neuroscience 1999;94(2):339-50.
1999: Bandmann O; Vaughan J; Holmans P A; Marsden C D; Wood N W
Toxins, genetics, and Parkinson's disease: the role of N-acetyltransferase 2.
Advances in neurology 1999;80():199-204.
1998: Valente E M; Warner T T; Jarman P R; Mathen D; Fletcher N A; Marsden C D; Bhatia K P; Wood N W
The role of DYT1 in primary torsion dystonia in Europe.
Brain : a journal of neurology 1998;121 ( Pt 12)():2335-9.
1998: Eve D J; Nisbet A P; Kingsbury A E; Hewson E L; Daniel S E; Lees A J; Marsden C D; Foster O J
Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease.
Brain research. Molecular brain research 1998;63(1):62-71.
1998: Kiriakakis V; Bhatia K P; Quinn N P; Marsden C D
The natural history of tardive dystonia. A long-term follow-up study of 107 cases.
Brain : a journal of neurology 1998;121 ( Pt 11)():2053-66.
1998: Schrag A; Ben-Shlomo Y; Brown R; Marsden C D; Quinn N
Young-onset Parkinson's disease revisited--clinical features, natural history, and mortality.
Movement disorders : official journal of the Movement Disorder Society 1998;13(6):885-94.
1998: Barker R A; Revesz T; Thom M; Marsden C D; Brown P
Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity.
Journal of neurology, neurosurgery, and psychiatry 1998;65(5):633-40.
1998: Bandmann O; Valente E M; Holmans P; Surtees R A; Walters J H; Wevers R A; Marsden C D; Wood N W
Dopa-responsive dystonia: a clinical and molecular genetic study.
Annals of neurology 1998;44(4):649-56.
1998: McNaught K S; Carrupt P A; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden C D
Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease.
Biochemical pharmacology 1998;56(8):921-33.
1998: Bhatia K P; Marsden C D; Thomas D G
Posteroventral pallidotomy can ameliorate attacks of paroxysmal dystonia induced by exercise.
Journal of neurology, neurosurgery, and psychiatry 1998;65(4):604-5.
1998: Phillips H A; Scheffer I E; Crossland K M; Bhatia K P; Fish D R; Marsden C D; Howell S J; Stephenson J B; Tolmie J; Plazzi G; Eeg-Olofsson O; Singh R; Lopes-Cendes I; Andermann E; Andermann F; Berkovic S F; Mulley J C
Autosomal dominant nocturnal frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24.
American journal of human genetics 1998;63(4):1108-16.
1998: Watts P M; Riedl A G; Douek D C; Edwards R J; Boobis A R; Jenner P; Marsden C D
Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase.
Neuroscience 1998;86(2):511-9.
1998: Marsden C D; Olanow C W
The causes of Parkinson's disease are being unraveled and rational neuroprotective therapy is close to reality.
Annals of neurology 1998;44(3 Suppl 1):S189-96.
1998: Vaughan J; Durr A; Tassin J; Bereznai B; Gasser T; Bonifati V; De Michele G; Fabrizio E; Volpe G; Bandmann O; Johnson W G; Golbe L I; Breteler M; Meco G; Agid Y; Brice A; Marsden C D; Wood N W
The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's Disease.
Annals of neurology 1998;44(2):270-3.
1998: Neville B G; Besag F M; Marsden C D
Exercise induced steroid dependent dystonia, ataxia, and alternating hemiplegia associated with epilepsy.
Journal of neurology, neurosurgery, and psychiatry 1998;65(2):241-4.
1998: Berardelli A; Rothwell J C; Hallett M; Thompson P D; Manfredi M; Marsden C D
The pathophysiology of primary dystonia.
Brain : a journal of neurology 1998;121 ( Pt 7)():1195-212.
1998: Kompoliti K; Goetz C G; Boeve B F; Maraganore D M; Ahlskog J E; Marsden C D; Bhatia K P; Greene P E; Przedborski S; Seal E C; Burns R S; Hauser R A; Gauger L L; Factor S A; Molho E S; Riley D E
Clinical presentation and pharmacological therapy in corticobasal degeneration.
Archives of neurology 1998;55(7):957-61.
1998: Schrag A; Rinne J O; Burn D J; Mathias C J; Marsden C D; Brooks D J; Quinn N P
Olivopontocerebellar atrophy and multiple system atrophy: clinical follow-up of 10 patients studied with PET.
Annals of neurology 1998;44(1):151-2.
1998: Dressler D; Rothwell J C; Marsden C D
Comparing biological potencies of Botox and Dysport with a mouse diaphragm model may mislead.
Journal of neurology 1998;245(6-7):332.
1998: Gu M; Owen A D; Toffa S E; Cooper J M; Dexter D T; Jenner P; Marsden C D; Schapira A H
Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
Journal of the neurological sciences 1998;158(1):24-9.
1998: Kidd D; Thompson P D; Day B L; Rothwell J C; Kendall B E; Thompson A J; Marsden C D; McDonald W I
Central motor conduction time in progressive multiple sclerosis. Correlations with MRI and disease activity.
Brain : a journal of neurology 1998;121 ( Pt 6)():1109-16.
1998: Brown P; Marsden C D
What do the basal ganglia do?
Lancet 1998;351(9118):1801-4.
1998: McAuley J H; Rothwell J C; Marsden C D; Findley L J
Electrophysiological aids in distinguishing organic from psychogenic tremor.
Neurology 1998;50(6):1882-4.
1998: Farmer S F; Sheean G L; Mayston M J; Rothwell J C; Marsden C D; Conway B A; Halliday D M; Rosenberg J R; Stephens J A
Abnormal motor unit synchronization of antagonist muscles underlies pathological co-contraction in upper limb dystonia.
Brain : a journal of neurology 1998;121 ( Pt 5)():801-14.
1998: Hall F S; Wilkinson L S; Humby T; Inglis W; Kendall D A; Marsden C A; Robbins T W
Isolation rearing in rats: pre- and postsynaptic changes in striatal dopaminergic systems.
Pharmacology, biochemistry, and behavior 1998;59(4):859-72.
1998: Vaughan J R; Farrer M J; Wszolek Z K; Gasser T; Durr A; Agid Y; Bonifati V; DeMichele G; Volpe G; Lincoln S; Breteler M; Meco G; Brice A; Marsden C D; Hardy J; Wood N W
Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD).
Human molecular genetics 1998;7(4):751-3.
1998: Platz T; Brown R G; Marsden C D
Training improves the speed of aimed movements in Parkinson's disease.
Brain : a journal of neurology 1998;121 ( Pt 3)():505-14.
1998: Hanna M G; Davis M B; Sweeney M G; Noursadeghi M; Ellis C J; Elliot P; Wood N W; Marsden C D
Generalized chorea in two patients harboring the Friedreich's ataxia gene trinucleotide repeat expansion.
Movement disorders : official journal of the Movement Disorder Society 1998;13(2):339-40.
1998: Playford E D; Passingham R E; Marsden C D; Brooks D J
Increased activation of frontal areas during arm movement in idiopathic torsion dystonia.
Movement disorders : official journal of the Movement Disorder Society 1998;13(2):309-18.
1998: Pearce R K; Banerji T; Jenner P; Marsden C D
De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset.
Movement disorders : official journal of the Movement Disorder Society 1998;13(2):234-41.
1998: Riedl A G; Watts P M; Jenner P; Marsden C D
P450 enzymes and Parkinson's disease: the story so far.
Movement disorders : official journal of the Movement Disorder Society 1998;13(2):212-20.
1998: Bandmann O; Marsden C D; Wood N W
Genetic aspects of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1998;13(2):203-11.
1998: Day B L; Thompson P D; Harding A E; Marsden C D
Influence of vision on upper limb reaching movements in patients with cerebellar ataxia.
Brain : a journal of neurology 1998;121 ( Pt 2)():357-72.
1998: Manji H; Howard R S; Miller D H; Hirsch N P; Carr L; Bhatia K; Quinn N; Marsden C D;
Status dystonicus: the syndrome and its management.
Brain : a journal of neurology 1998;121 ( Pt 2)():243-52.
1998: Crimlisk H L; Bhatia K; Cope H; David A; Marsden C D; Ron M A
Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms.
BMJ (Clinical research ed.) 1998;316(7131):582-6.
1998: Silva M T; Rose S; Hindmarsh J G; Jenner P; Marsden C D
L-arginine produces NO-independent increases in dopamine efflux in rat striatum.
Neuroreport 1998;9(1):149-52.
1998: Samuel M; Caputo E; Brooks D J; Schrag A; Scaravilli T; Branston N M; Rothwell J C; Marsden C D; Thomas D G; Lees A J; Quinn N P
A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications.
Brain : a journal of neurology 1998;121 ( Pt 1)():59-75.
1998: Dressler D; Scaravilli T; Bhatia K P; Marsden C D
Nicotine nasal spray is not reliable treatment for blepharospasm: results of a pilot study.
Movement disorders : official journal of the Movement Disorder Society 1998;13(1):190.
1998: Marsden C D
The apraxias are higher-order defects of sensorimotor integration.
Novartis Foundation symposium 1998;218():308-25; discussion 326-31.
1998: Marsden C D; Fahn S
Dystomia 3. Summary and conclusions.
Advances in neurology 1998;78():359-64.
1998: Bandmann O; Marsden C D; Wood N W
Atypical presentations of dopa-responsive dystonia.
Advances in neurology 1998;78():283-90.
1998: Fahn S; Bressman S B; Marsden C D
Classification of dystonia.
Advances in neurology 1998;78():1-10.
1998: Rinne U K; Bracco F; Chouza C; Dupont E; Gershanik O; Marti Masso J F; Montastruc J L; Marsden C D
Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial. The PKDS009 Study Group.
Drugs 1998;55 Suppl 1():23-30.
1998: Marsden C D
Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.
Drugs 1998;55 Suppl 1():17-22.
1997: Jarman P R; Davis M B; Hodgson S V; Marsden C D; Wood N W
Paroxysmal dystonic choreoathetosis. Genetic linkage studies in a British family.
Brain : a journal of neurology 1997;120 ( Pt 12)():2125-30.
1997: Bhatia K P; Quinn N P; Marsden C D
Clinical features and natural history of axial predominant adult onset primary dystonia.
Journal of neurology, neurosurgery, and psychiatry 1997;63(6):788-91.
1997: Bandmann O; Sweeney M G; Daniel S E; Wenning G K; Quinn N; Marsden C D; Wood N W
Multiple-system atrophy is genetically distinct from identified inherited causes of spinocerebellar degeneration.
Neurology 1997;49(6):1598-604.
1997: Brown P; Quinn N P; Barnes D; Wren D R; Marsden C D
Spinal rigidity following acute myelitis.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):1056-9.
1997: Bhatia K P; Soland V L; Bhatt M H; Quinn N P; Marsden C D
Paroxysmal exercise-induced dystonia: eight new sporadic cases and a review of the literature.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):1007-12.
1997: Brown P; Rothwell J C; Stevens J M; Lees A J; Marsden C D
Cerebellar axial postural tremor.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):977-84.
1997: Smith L A; Gordin A; Jenner P; Marsden C D
Entacapone enhances levodopa-induced reversal of motor disability in MPTP-treated common marmosets.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):935-45.
1997: Eve D J; Nisbet A P; Kingsbury A E; Temlett J; Marsden C D; Foster O J
Selective increase in somatostatin mRNA expression in human basal ganglia in Parkinson's disease.
Brain research. Molecular brain research 1997;50(1-2):59-70.
1997: Jarman P R; Wood N W; Davis M T; Davis P V; Bhatia K P; Marsden C D; Davis M B
Hereditary geniospasm: linkage to chromosome 9q13-q21 and evidence for genetic heterogeneity.
American journal of human genetics 1997;61(4):928-33.
1997: Bandmann O; Vaughan J; Holmans P; Marsden C D; Wood N W
Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease.
Lancet 1997;350(9085):1136-9.
1997: Barbato L; Stocchi F; Monge A; Vacca L; Ruggieri S; Nordera G; Marsden C D
The long-duration action of levodopa may be due to a postsynaptic effect.
Clinical neuropharmacology 1997;20(5):394-401.
1997: Anastasopoulos D; Bhatia K; Bronstein A M; Marsden C D; Gresty M A
Perception of spatial orientation in spasmodic torticollis. Part 2: The visual vertical.
Movement disorders : official journal of the Movement Disorder Society 1997;12(5):709-14.
1997: Jarman P R; Bandmann O; Marsden C D; Wood N W
GTP cyclohydrolase I mutations in patients with dystonia responsive to anticholinergic drugs.
Journal of neurology, neurosurgery, and psychiatry 1997;63(3):304-8.
1997: Alam Z I; Jenner A; Daniel S E; Lees A J; Cairns N; Marsden C D; Jenner P; Halliwell B
Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.
Journal of neurochemistry 1997;69(3):1196-203.
1997: Soliveri P; Brown R G; Jahanshahi M; Caraceni T; Marsden C D
Learning manual pursuit tracking skills in patients with Parkinson's disease.
Brain : a journal of neurology 1997;120 ( Pt 8)():1325-37.
1997: Anastasopoulos D; Bhatia K; Bisdorff A; Bronstein A M; Gresty M A; Marsden C D
Perception of spatial orientation in spasmodic torticollis. Part I: The postural vertical.
Movement disorders : official journal of the Movement Disorder Society 1997;12(4):561-9.
1997: Wenning G K; Odin P; Morrish P; Rehncrona S; Widner H; Brundin P; Rothwell J C; Brown R; Gustavii B; Hagell P; Jahanshahi M; Sawle G; Björklund A; Brooks D J; Marsden C D; Quinn N P; Lindvall O
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.
Annals of neurology 1997;42(1):95-107.
1997: Mackenzie G M; Jackson M J; Jenner P; Marsden C D
Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmoset.
Synapse (New York, N.Y.) 1997;26(3):301-16.
1997: Planté-Bordeneuve V; Taussig D; Thomas F; Said G; Wood N W; Marsden C D; Harding A E
Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele.
Neurology 1997;48(6):1589-93.
1997: McAuley J H; Rothwell J C; Marsden C D
Frequency peaks of tremor, muscle vibration and electromyographic activity at 10 Hz, 20 Hz and 40 Hz during human finger muscle contraction may reflect rhythmicities of central neural firing.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1997;114(3):525-41.
1997: Kew J J; Halligan P W; Marshall J C; Passingham R E; Rothwell J C; Ridding M C; Marsden C D; Brooks D J
Abnormal access of axial vibrotactile input to deafferented somatosensory cortex in human upper limb amputees.
Journal of neurophysiology 1997;77(5):2753-64.
1997: Gu M; Gash M T; Cooper J M; Wenning G K; Daniel S E; Quinn N P; Marsden C D; Schapira A H
Mitochondrial respiratory chain function in multiple system atrophy.
Movement disorders : official journal of the Movement Disorder Society 1997;12(3):418-22.
1997: Lekhel H; Popov K; Anastasopoulos D; Bronstein A; Bhatia K; Marsden C D; Gresty M
Postural responses to vibration of neck muscles in patients with idiopathic torticollis.
Brain : a journal of neurology 1997;120 ( Pt 4)():583-91.
1997: Ceballos-Baumann A O; Sheean G; Passingham R E; Marsden C D; Brooks D J
Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study.
Brain : a journal of neurology 1997;120 ( Pt 4)():571-82.
1997: Barker R A; Marsden C D
Successful treatment of stiff man syndrome with intravenous immunoglobulin.
Journal of neurology, neurosurgery, and psychiatry 1997;62(4):426-7.
1997: Bandmann O; Sweeney M G; Daniel S E; Marsden C D; Wood N W
Mitochondrial DNA polymorphisms in pathologically proven Parkinson's disease.
Journal of neurology 1997;244(4):262-5.
1997: Stocchi F; Nordera G; Marsden C D
Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias.
Clinical neuropharmacology 1997;20(2):95-115.
1997: Sian J; Dexter D T; Cohen G; Jenner P G; Marsden C D
Comparison of HPLC and enzymatic recycling assays for the measurement of oxidized glutathione in rat brain.
The Journal of pharmacy and pharmacology 1997;49(3):332-5.
1997: Werhahn K J; Brown P; Thompson P D; Marsden C D
The clinical features and prognosis of chronic posthypoxic myoclonus.
Movement disorders : official journal of the Movement Disorder Society 1997;12(2):216-20.
1997: Rinne U K; Bracco F; Chouza C; Dupont E; Gershanik O; Marti Masso J F; Montastruc J L; Marsden C D; Dubini A; Orlando N; Grimaldi R
Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group.
Neurology 1997;48(2):363-8.
1997: Leiguarda R C; Pramstaller P P; Merello M; Starkstein S; Lees A J; Marsden C D
Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.
Brain : a journal of neurology 1997;120 ( Pt 1)():75-90.
1997: Brown P; Rothwell J C; Marsden C D
The stiff leg syndrome.
Journal of neurology, neurosurgery, and psychiatry 1997;62(1):31-7.
1997: Boecker H; Wills A J; Ceballos-Baumann A; Samuel M; Thomas D G; Marsden C D; Brooks D J
Stereotactic thalamotomy in tremor-dominant Parkinson's disease: an H2(15)O PET motor activation study.
Annals of neurology 1997;41(1):108-11.
1997: Owen A D; Schapira A H; Jenner P; Marsden C D
Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies.
Journal of neural transmission. Supplementum 1997;51():167-73.
1997: Pearce R K; Owen A; Daniel S; Jenner P; Marsden C D
Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 1997;104(6-7):661-77.
1997: Marsden C D; Linazasoro G; Obeso J A
An introduction to the new surgery for Parkinson's disease. Past and present problems.
Advances in neurology 1997;74():143-7.
1997: Foong J; Ridding M; Cope H; Marsden C D; Ron M A
Corticospinal function in conversion disorder.
The Journal of neuropsychiatry and clinical neurosciences 1997;9(2):302-3.
1997: Toffa S; Kunikowska G M; Zeng B Y; Jenner P; Marsden C D
Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration.
Journal of neural transmission (Vienna, Austria : 1996) 1997;104(1):67-75.
1996: Riedl A G; Watts P M; Edwards R J; Boobis A R; Jenner P; Marsden C D
Selective localisation of P450 enzymes and NADPH-P450 oxidoreductase in rat basal ganglia using anti-peptide antisera.
Brain research 1996;743(1-2):324-8.
1996: Hurley M J; Stubbs C M; Jenner P; Marsden C D
Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neuroleptics.
European journal of pharmacology 1996;318(2-3):283-93.
1996: Seaton T A; Jenner P; Marsden C D
Mitochondrial respiratory enzyme function and superoxide dismutase activity following brain glutathione depletion in the rat.
Biochemical pharmacology 1996;52(11):1657-63.
1996: Hurley M J; Stubbs C M; Jenner P; Marsden C D
Effect of chronic treatment with typical and atypical neuroleptics on the expression of dopamine D2 and D3 receptors in rat brain.
Psychopharmacology 1996;128(4):362-70.
1996: Steiger M J; Thompson P D; Marsden C D
Disordered axial movement in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1996;61(6):645-8.
1996: Nisbet A P; Eve D J; Kingsbury A E; Daniel S E; Marsden C D; Lees A J; Foster O J
Glutamate decarboxylase-67 messenger RNA expression in normal human basal ganglia and in Parkinson's disease.
Neuroscience 1996;75(2):389-406.
1996: Soland V L; Bhatia K P; Sheean G L; Marsden C D
Hereditary geniospasm: two new families.
Movement disorders : official journal of the Movement Disorder Society 1996;11(6):744-6.
1996: Kullmann D M; Howard R S; Miller D H; Hirsch N P; Brown P; Marsden C D
Brainstem encephalopathy with stimulus-sensitive myoclonus leading to respiratory arrest, but with recovery: a description of two cases and review of the literature.
Movement disorders : official journal of the Movement Disorder Society 1996;11(6):715-8.
1996: Soland V L; Bhatia K P; Volonte M A; Marsden C D
Focal task-specific tremors.
Movement disorders : official journal of the Movement Disorder Society 1996;11(6):665-70.
1996: Fletcher N A; Marsden C D
Dyskinetic cerebral palsy: a clinical and genetic study.
Developmental medicine and child neurology 1996;38(10):873-80.
1996: McNaught K S; Thull U; Carrupt P A; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden C D
Nigral cell loss produced by infusion of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration 1996;5(3):265-74.
1996: Bandmann O; Daniel S; Marsden C D; Wood N W; Harding A E
The GTP-cyclohydrolase I gene in atypical parkinsonian patients: a clinico-genetic study.
Journal of the neurological sciences 1996;141(1-2):27-32.
1996: Wenning G K; Granata R; Laboyrie P M; Quinn N P; Jenner P; Marsden C D
Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration.
Movement disorders : official journal of the Movement Disorder Society 1996;11(5):522-32.
1996: Hurley M J; Stubbs C M; Jenner P; Marsden C D
D3 receptor expression within the basal ganglia is not affected by Parkinson's disease.
Neuroscience letters 1996;214(2-3):75-8.
1996: Turjanski N; Pirtosek Z; Quirk J; Anderson T J; Rivest J; Marsden C D; Lees A J
Botulinum toxin in the treatment of writer's cramp.
Clinical neuropharmacology 1996;19(4):314-20.
1996: Brown P; Marsden C D
Rhythmic cortical and muscle discharge in cortical myoclonus.
Brain : a journal of neurology 1996;119 ( Pt 4)():1307-16.
1996: Quirk J A; Sheean G L; Marsden C D; Lees A J
Treatment of nonoccupational limb and trunk dystonia with botulinum toxin.
Movement disorders : official journal of the Movement Disorder Society 1996;11(4):377-83.
1996: Pearce R K; Collins P; Jenner P; Emmett C; Marsden C D
Intraventricular infusion of basic fibroblast growth factor (bFGF) in the MPTP-treated common marmoset.
Synapse (New York, N.Y.) 1996;23(3):192-200.
1996: McNaught K S; Thull U; Carrupt P A; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden C D
Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Biochemical pharmacology 1996;52(1):29-34.
1996: Bandmann O; Davis M B; Marsden C D; Wood N W
The human homologue of the weaver mouse gene in familial and sporadic Parkinson's disease.
Neuroscience 1996;72(4):877-9.
1996: Owen A D; Schapira A H; Jenner P; Marsden C D
Oxidative stress and Parkinson's disease.
Annals of the New York Academy of Sciences 1996;786():217-23.
1996: Fernandez A; de Ceballos M L; Rose S; Jenner P; Marsden C D
Alterations in peptide levels in Parkinson's disease and incidental Lewy body disease.
Brain : a journal of neurology 1996;119 ( Pt 3)():823-30.
1996: Bain P G; Britton T C; Jenkins I H; Thompson P D; Rothwell J C; Thomas P K; Brooks D J; Marsden C D
Tremor associated with benign IgM paraproteinaemic neuropathy.
Brain : a journal of neurology 1996;119 ( Pt 3)():789-99.
1996: Zeng B Y; Jenner P; Marsden C D
Altered motor function and graft survival produced by basic fibroblast growth factor in rats with 6-OHDA lesions and fetal ventral mesencephalic grafts are associated with glial proliferation.
Experimental neurology 1996;139(2):214-26.
1996: McNaught K S; Thull U; Carrupt P A; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden C D
Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration.
Biochemical pharmacology 1996;51(11):1503-11.
1996: Berardelli A; Hallett M; Rothwell J C; Agostino R; Manfredi M; Thompson P D; Marsden C D
Single-joint rapid arm movements in normal subjects and in patients with motor disorders.
Brain : a journal of neurology 1996;119 ( Pt 2)():661-74.
1996: Cockerell O C; Rothwell J; Thompson P D; Marsden C D; Shorvon S D
Clinical and physiological features of epilepsia partialis continua. Cases ascertained in the UK.
Brain : a journal of neurology 1996;119 ( Pt 2)():393-407.
1996: Seaton T A; Jenner P; Marsden C D
The isomers of thioctic acid alter C-deoxyglucose incorporation in rat basal ganglia.
Biochemical pharmacology 1996;51(7):983-6.
1996: Bandmann O; Nygaard T G; Surtees R; Marsden C D; Wood N W; Harding A E
Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity.
Human molecular genetics 1996;5(3):403-6.
1996: McNaught K S; Thull U; Carrupt P A; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden C D
Toxicity to PC12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Neuroscience letters 1996;206(1):37-40.
1996: Klein C; Wenning G K; Quinn N P; Marsden C D
Ataxia without telangiectasia masquerading as benign hereditary chorea.
Movement disorders : official journal of the Movement Disorder Society 1996;11(2):217-20.
1996: Smith L; De Salvia M; Jenner P; Marsden C D
An appraisal of the antiparkinsonian activity of piribedil in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets.
Movement disorders : official journal of the Movement Disorder Society 1996;11(2):125-35.
1996: Bhatia K P; Turjanski N; Brooks D J; Marsden C D; Thrush D
The usefulness of functional imaging in movement disorders: an illustrative case.
Journal of neurology, neurosurgery, and psychiatry 1996;60(3):353-4.
1996: Hurley M J; Jolkkonen J; Stubbs C M; Jenner P; Marsden C D
Dopamine D3 receptors in the basal ganglia of the common marmoset and following MPTP and L-DOPA treatment.
Brain research 1996;709(2):259-64.
1996: Soland V L; Bhatia K P; Marsden C D
Sex prevalence of focal dystonias.
Journal of neurology, neurosurgery, and psychiatry 1996;60(2):204-5.
1996: Pramstaller P P; Marsden C D
The basal ganglia and apraxia.
Brain : a journal of neurology 1996;119 ( Pt 1)():319-40.
1996: Brown P; Ridding M C; Werhahn K J; Rothwell J C; Marsden C D
Abnormalities of the balance between inhibition and excitation in the motor cortex of patients with cortical myoclonus.
Brain : a journal of neurology 1996;119 ( Pt 1)():309-317.
1996: Steiger M J; El-Debas T; Anderson T; Findley L J; Marsden C D
Double-blind study of the activity and tolerability of cabergoline versus placebo in parkinsonians with motor fluctuations.
Journal of neurology 1996;243(1):68-72.
1996: Wenning G K; Quinn N P; Daniel S E; Garratt H; Marsden C D
Facial dystonia in pathologically proven multiple system atrophy: a video report.
Movement disorders : official journal of the Movement Disorder Society 1996;11(1):107-9.
1996: Zeng B Y; Jenner P; Marsden C D
Partial reversal of increased preproenkephalin messenger ribonucleic acid (mRNA) and decreased preprotachykinin mRNA by foetal dopamine cells in unilateral 6-hydroxydopamine-lesioned rat striatum parallels functional recovery.
Movement disorders : official journal of the Movement Disorder Society 1996;11(1):43-52.
1996: Seaton T A; Jenner P; Marsden C D
Thioctic acid does not restore glutathione levels or protect against the potentiation of 6-hydroxydopamine toxicity induced by glutathione depletion in rat brain.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(3):315-29.
1996: Granata R; Wenning G K; Jolkkonen J; Jenner P; Marsden C D
Effect of repeated administration of dopamine agonists on striatal neuropeptide mRNA expression in rats with a unilateral nigral 6-hydroxydopamine lesion.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(3):249-60.
1996: Marsden C D; Deecke L; Freund H J; Hallett M; Passingham R E; Shibasaki H; Tanji J; Wiesendanger M
The functions of the supplementary motor area. Summary of a workshop.
Advances in neurology 1996;70():477-87.
1996: Marsden C D
Paroxysmal choreoathetosis.
Advances in neurology 1996;70():467-70.
1995: Bain P G; Findley L J; Britton T C; Rothwell J C; Gresty M A; Thompson P D; Marsden C D
Primary writing tremor.
Brain : a journal of neurology 1995;118 ( Pt 6)():1461-72.
1995: Haaxma R; van Boxtel A; Brouwer W H; Goeken L N; Denier van der Gon J J; Colebatch J G; Martin A; Brooks D J; Noth J; Marsden C D
Motor function in a patient with bilateral lesions of the globus pallidus.
Movement disorders : official journal of the Movement Disorder Society 1995;10(6):761-77.
1995: Pearce R K; Jackson M; Smith L; Jenner P; Marsden C D
Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).
Movement disorders : official journal of the Movement Disorder Society 1995;10(6):731-40.
1995: McNaught K S; Thull U; Carrupt P A; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden C D
Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Biochemical pharmacology 1995;50(11):1903-11.
1995: Bhatia K P; Brown P; Gregory R; Lennox G G; Manji H; Thompson P D; Ellison D W; Marsden C D
Progressive myoclonic ataxia associated with coeliac disease. The myoclonus is of cortical origin, but the pathology is in the cerebellum.
Brain : a journal of neurology 1995;118 ( Pt 5)():1087-93.
1995: Van der Kamp W; Rothwell J C; Thompson P D; Day B L; Marsden C D
The movement-related cortical potential is abnormal in patients with idiopathic torsion dystonia.
Movement disorders : official journal of the Movement Disorder Society 1995;10(5):630-3.
1995: MacKenzie G M; Jenner P; Marsden C D
Effect of 7-nitro indazole on quinolinic acid-induced striatal toxicity in the rat.
Neuroreport 1995;6(13):1789-94.
1995: Bhatia K P; Marsden C D
Reflex sympathetic dystrophy. May be accompanied by involuntary movements.
BMJ (Clinical research ed.) 1995;311(7008):811-2.
1995: Jolkkonen J; Jenner P; Marsden C D
L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP.
Brain research. Molecular brain research 1995;32(2):297-307.
1995: Burn D J; Rinne J O; Quinn N P; Lees A J; Marsden C D; Brooks D J
Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET study.
Brain : a journal of neurology 1995;118 ( Pt 4)():951-8.
1995: Jahanshahi M; Jenkins I H; Brown R G; Marsden C D; Passingham R E; Brooks D J
Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects.
Brain : a journal of neurology 1995;118 ( Pt 4)():913-33.
1995: Jolkkonen J; Granata R; Jenner P; Marsden C D
Acute and subchronic effects of dopamine agonists on neuropeptide gene expression in the rat striatum.
Neuropeptides 1995;29(2):109-14.
1995: Quinn N P; Wenning G; Marsden C D
The Shy-Drager syndrome. What did Shy and Drager really describe?
Archives of neurology 1995;52(7):656-7.
1995: Bandmann O; Davis M B; Marsden C D; Harding A E
Sequence of the superoxide dismutase 1 (SOD 1) gene in familial Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1995;59(1):90-1.
1995: Sheean G L; Murray N M; Marsden C D
Pain and remote weakness in limbs injected with botulinum toxin A for writer's cramp.
Lancet 1995;346(8968):154-6.
1995: Tranchant C; Bhatia K P; Marsden C D
Movement disorders in multiple sclerosis.
Movement disorders : official journal of the Movement Disorder Society 1995;10(4):418-23.
1995: MacKenzie G M; Jenner P; Marsden C D
The effect of nitric oxide synthase inhibition on quinolinic acid toxicity in the rat striatum.
Neuroscience 1995;67(2):357-71.
1995: Touge T; Werhahn K J; Rothwell J C; Marsden C D
Movement-related cortical potentials preceding repetitive and random-choice hand movements in Parkinson's disease.
Annals of neurology 1995;37(6):791-9.
1995: Ceballos-Baumann A O; Passingham R E; Marsden C D; Brooks D J
Motor reorganization in acquired hemidystonia.
Annals of neurology 1995;37(6):746-57.
1995: Gnanalingham K K; Hunter A J; Jenner P; Marsden C D
Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat--relationship to circling behaviour.
Biochemical pharmacology 1995;49(9):1185-93.
1995: Rinne J O; Burn D J; Mathias C J; Quinn N P; Marsden C D; Brooks D J
Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy.
Annals of neurology 1995;37(5):568-73.
1995: Lange K W; Sahakian B J; Quinn N P; Marsden C D; Robbins T W
Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia.
Journal of neurology, neurosurgery, and psychiatry 1995;58(5):598-606.
1995: McNaught K S; Altomare C; Cellamare S; Carotti A; Thull U; Carrupt P A; Testa B; Jenner P; Marsden C D
Inhibition of alpha-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Neuroreport 1995;6(8):1105-8.
1995: Cooper J M; Daniel S E; Marsden C D; Schapira A H
L-dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain.
Movement disorders : official journal of the Movement Disorder Society 1995;10(3):295-7.
1995: Zeng B Y; Jolkkonen J; Jenner P; Marsden C D
Chronic L-DOPA treatment differentially regulates gene expression of glutamate decarboxylase, preproenkephalin and preprotachykinin in the striatum of 6-hydroxydopamine-lesioned rat.
Neuroscience 1995;66(1):19-28.
1995: Goetz C G; Stebbins G T; Chmura T A; Fahn S; Klawans H L; Marsden C D
Teaching tape for the motor section of the unified Parkinson's disease rating scale.
Movement disorders : official journal of the Movement Disorder Society 1995;10(3):263-6.
1995: Nisbet A P; Foster O J; Kingsbury A; Eve D J; Daniel S E; Marsden C D; Lees A J
Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease.
Neuroscience 1995;66(2):361-76.
1995: Playford E D; Britton T C; Thompson P D; Brooks D J; Findley L J; Marsden C D
Exacerbation of postural tremor with emergence of parkinsonism after treatment with neuroleptic drugs.
Journal of neurology, neurosurgery, and psychiatry 1995;58(4):487-9.
1995: Gnanalingham K K; Milkowski N A; Smith L A; Hunter A J; Jenner P; Marsden C D
Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset.
European journal of pharmacology 1995;277(2-3):235-41.
1995: Orrell R W; Amrolia P J; Heald A; Cleland P G; Owen J S; Morgan-Hughes J A; Harding A E; Marsden C D
Acanthocytosis, retinitis pigmentosa, and pallidal degeneration: a report of three patients, including the second reported case with hypoprebetalipoproteinemia (HARP syndrome).
Neurology 1995;45(3 Pt 1):487-92.
1995: Markus H S; Lees A J; Lennox G; Marsden C D; Costa D C
Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls.
Movement disorders : official journal of the Movement Disorder Society 1995;10(2):179-87.
1995: Ceballos-Baumann A O; Passingham R E; Warner T; Playford E D; Marsden C D; Brooks D J
Overactive prefrontal and underactive motor cortical areas in idiopathic dystonia.
Annals of neurology 1995;37(3):363-72.
1995: Scheffer I E; Bhatia K P; Lopes-Cendes I; Fish D R; Marsden C D; Andermann E; Andermann F; Desbiens R; Keene D; Cendes F
Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder.
Brain : a journal of neurology 1995;118 ( Pt 1)():61-73.
1995: Davie C A; Wenning G K; Barker G J; Tofts P S; Kendall B E; Quinn N; McDonald W I; Marsden C D; Miller D H
Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy.
Annals of neurology 1995;37(2):204-10.
1995: Gnanalingham K K; Hunter A J; Jenner P; Marsden C D
The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's disease.
Psychopharmacology 1995;117(3):287-97.
1995: Gnanalingham K K; Erol D D; Hunter A J; Smith L A; Jenner P; Marsden C D
Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset.
Psychopharmacology 1995;117(3):275-86.
1995: Kingsbury A E; Foster O J; Nisbet A P; Cairns N; Bray L; Eve D J; Lees A J; Marsden C D
Tissue pH as an indicator of mRNA preservation in human post-mortem brain.
Brain research. Molecular brain research 1995;28(2):311-8.
1995: Gnanalingham K K; Hunter A J; Jenner P; Marsden C D
Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
Psychopharmacology 1995;117(4):403-12.
1995: Vidailhet M; Atchison P R; Stocchi F; Thompson P D; Rothwell J C; Marsden C D
The bereitschaftspotential preceding stepping in patients with isolated gait ignition failure.
Movement disorders : official journal of the Movement Disorder Society 1995;10(1):18-21.
1995: Silva M T; Rose S; Hindmarsh J G; Aislaitner G; Gorrod J W; Moore P K; Jenner P; Marsden C D
Increased striatal dopamine efflux in vivo following inhibition of cerebral nitric oxide synthase by the novel monosodium salt of 7-nitro indazole.
British journal of pharmacology 1995;114(2):257-8.
1995: Jolkkonen J; Jenner P; Marsden C D
Glutamatergic regulation of striatal peptide gene expression in rats.
Journal of neural transmission. Parkinson's disease and dementia section 1995;10(2-3):187-98.
1995: Lee M S; Marsden C D
Drop attacks.
Advances in neurology 1995;67():41-52.
1995: Toro C; Hallett M; Rothwell J C; Asselman P T; Marsden C D
Physiology of negative myoclonus.
Advances in neurology 1995;67():211-7.
1995: Gnanalingham K K; Milkowski N A; Smith L A; Hunter A J; Jenner P; Marsden C D
Short and long-term changes in cerebral [14C]-2-deoxyglucose uptake in the MPTP-treated marmoset: relationship to locomotor activity.
Journal of neural transmission. General section 1995;101(1-3):65-82.
1995: Marsden C D
Psychogenic problems associated with dystonia.
Advances in neurology 1995;65():319-26.
1995: Fernandez A; Jenner P; Marsden C D; De Ceballos M L
Characterization of neurotensin-like immunoreactivity in human basal ganglia: increased neurotensin levels in substantia nigra in Parkinson's disease.
Peptides 1995;16(2):339-46.
1994: Mann V M; Cooper J M; Daniel S E; Srai K; Jenner P; Marsden C D; Schapira A H
Complex I, iron, and ferritin in Parkinson's disease substantia nigra.
Annals of neurology 1994;36(6):876-81.
1994: Nakamura T; Bronstein A M; Lueck C; Marsden C D; Rudge P
Vestibular, cervical and visual remembered saccades in Parkinson's disease.
Brain : a journal of neurology 1994;117 ( Pt 6)():1423-32.
1994: Sawle G V; Marsden C D
Dopa-responsive dystonia.
Annals of neurology 1994;36(5):801-3.
1994: Lera G; Bhatia K; Marsden C D
Dystonia as the major manifestation of Leigh's syndrome.
Movement disorders : official journal of the Movement Disorder Society 1994;9(6):642-9.
1994: Thompson P D; Bhatia K P; Brown P; Davis M B; Pires M; Quinn N P; Luthert P; Honovar M; O'Brien M D; Marsden C D
Cortical myoclonus in Huntington's disease.
Movement disorders : official journal of the Movement Disorder Society 1994;9(6):633-41.
1994: Thompson P D; Day B L; Rothwell J C; Brown P; Britton T C; Marsden C D
The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus.
Brain : a journal of neurology 1994;117 ( Pt 5)():1197-207.
1994: Rinne J O; Lee M S; Thompson P D; Marsden C D
Corticobasal degeneration. A clinical study of 36 cases.
Brain : a journal of neurology 1994;117 ( Pt 5)():1183-96.
1994: Jolkkonen J; Jenner P; Marsden C D
GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatment.
Neuroscience letters 1994;180(2):273-6.
1994: MacKenzie G M; Rose S; Bland-Ward P A; Moore P K; Jenner P; Marsden C D
Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole.
Neuroreport 1994;5(15):1993-6.
1994: Schapira A H; Marsden C D
British neurology: a national focus.
Journal of neurology, neurosurgery, and psychiatry 1994;57(9):1136.
1994: Sian J; Dexter D T; Lees A J; Daniel S; Jenner P; Marsden C D
Glutathione-related enzymes in brain in Parkinson's disease.
Annals of neurology 1994;36(3):356-61.
1994: Sian J; Dexter D T; Lees A J; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden C D
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
Annals of neurology 1994;36(3):348-55.
1994: Brown P; Rothwell J C; Thompson P D; Marsden C D
Propriospinal myoclonus: evidence for spinal "pattern" generators in humans.
Movement disorders : official journal of the Movement Disorder Society 1994;9(5):571-6.
1994: Lee M S; Marsden C D
Neurological sequelae following carbon monoxide poisoning clinical course and outcome according to the clinical types and brain computed tomography scan findings.
Movement disorders : official journal of the Movement Disorder Society 1994;9(5):550-8.
1994: Caviness J N; Gabellini A; Kneebone C S; Thompson P D; Lees A J; Marsden C D
Unusual focal dyskinesias: the ears, the shoulders, the back, and the abdomen.
Movement disorders : official journal of the Movement Disorder Society 1994;9(5):531-8.
1994: Lee M S; Marsden C D
Movement disorders following lesions of the thalamus or subthalamic region.
Movement disorders : official journal of the Movement Disorder Society 1994;9(5):493-507.
1994: Rinne J O; Daniel S E; Scaravilli F; Harding A E; Marsden C D
Nigral degeneration in neuroacanthocytosis.
Neurology 1994;44(9):1629-32.
1994: Davis M B; Bateman D; Quinn N P; Marsden C D; Harding A E
Mutation analysis in patients with possible but apparently sporadic Huntington's disease.
Lancet 1994;344(8924):714-7.
1994: Dexter D T; Nanayakkara I; Goss-Sampson M A; Muller D P; Harding A E; Marsden C D; Jenner P
Nigral dopaminergic cell loss in vitamin E deficient rats.
Neuroreport 1994;5(14):1773-6.
1994: Lee M S; Rinne J O; Ceballos-Baumann A; Thompson P D; Marsden C D
Dystonia after head trauma.
Neurology 1994;44(8):1374-8.
1994: Planté-Bordeneuve V; Davis M B; Maraganore D M; Marsden C D; Harding A E
Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1994;57(8):911-3.
1994: Taylor D J; Krige D; Barnes P R; Kemp G J; Carroll M T; Mann V M; Cooper J M; Marsden C D; Schapira A H
A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease.
Journal of the neurological sciences 1994;125(1):77-81.
1994: Marsden C D; Obeso J A
The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease.
Brain : a journal of neurology 1994;117 ( Pt 4)():877-97.
1994: Bhatia K P; Marsden C D
The behavioural and motor consequences of focal lesions of the basal ganglia in man.
Brain : a journal of neurology 1994;117 ( Pt 4)():859-76.
1994: Bain P G; Findley L J; Thompson P D; Gresty M A; Rothwell J C; Harding A E; Marsden C D
A study of hereditary essential tremor.
Brain : a journal of neurology 1994;117 ( Pt 4)():805-24.
1994: Fernandez A; de Ceballos M L; Jenner P; Marsden C D
Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patients.
Neuroscience 1994;61(1):73-9.
1994: Bhatia K P; Lera G; Luthert P J; Marsden C D
Vascular chorea: case report with pathology.
Movement disorders : official journal of the Movement Disorder Society 1994;9(4):447-50.
1994: Rose S; Hindmarsh J G; Steiger M J; Bhatt M; Quinn N P; Jenner P; Marsden C D
Plasma HVA levels following debrisoquine administration do not reflect cerebral dopamine loss in early Parkinson's disease.
Clinical neuropharmacology 1994;17(3):260-9.
1994: Marsden C D
Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1994;57(6):672-81.
1994: Rinne J O; Daniel S E; Scaravilli F; Pires M; Harding A E; Marsden C D
The neuropathological features of neuroacanthocytosis.
Movement disorders : official journal of the Movement Disorder Society 1994;9(3):297-304.
1994: Gnanalingham K K; Hunter A J; Jenner P; Marsden C D
An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat.
Neuropharmacology 1994;33(5):647-55.
1994: Planté-Bordeneuve V; Davis M B; Maraganore D M; Marsden C D; Harding A E
Tyrosine hydroxylase polymorphism in familial and sporadic Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1994;9(3):337-9.
1994: Harwood G; Hierons R; Fletcher N A; Marsden C D
Lessons from a remarkable family with dopa-responsive dystonia.
Journal of neurology, neurosurgery, and psychiatry 1994;57(4):460-3.
1994: Leiguarda R; Lees A J; Merello M; Starkstein S; Marsden C D
The nature of apraxia in corticobasal degeneration.
Journal of neurology, neurosurgery, and psychiatry 1994;57(4):455-9.
1994: Rose S; Jenner P; Marsden C D
Chronic administration does not alter the accumulation of L-dopa into muscle.
Movement disorders : official journal of the Movement Disorder Society 1994;9(2):167-72.
1994: Orrell R W; Marsden C D
The neck-tongue syndrome.
Journal of neurology, neurosurgery, and psychiatry 1994;57(3):348-52.
1994: Dexter D T; Brooks D J; Harding A E; Burn D J; Muller D P; Goss-Sampson M A; Jenner P G; Marsden C D
Nigrostriatal function in vitamin E deficiency: clinical, experimental, and positron emission tomographic studies.
Annals of neurology 1994;35(3):298-303.
1994: Olanow C W; Marsden C D; Lang A E; Goetz C G
The role of surgery in Parkinson's disease management.
Neurology 1994;44(3 Suppl 1):S17-20.
1994: Nisbet A P; Foster O J; Kingsbury A; Lees A J; Marsden C D
Nitric oxide synthase mRNA expression in human subthalamic nucleus, striatum and globus pallidus: implications for basal ganglia function.
Brain research. Molecular brain research 1994;22(1-4):329-32.
1994: Stocchi F; Quinn N P; Barbato L; Patsalos P N; O'Connel M T; Ruggieri S; Marsden C D
Comparison between a fast and a slow release preparation of levodopa and a combination of the two: a clinical and pharmacokinetic study.
Clinical neuropharmacology 1994;17(1):38-44.
1994: Britton T C; Thompson P D; Day B L; Rothwell J C; Findley L J; Marsden C D
Rapid wrist movements in patients with essential tremor. The critical role of the second agonist burst.
Brain : a journal of neurology 1994;117 ( Pt 1)():39-47.
1994: Lindvall O; Sawle G; Widner H; Rothwell J C; Björklund A; Brooks D; Brundin P; Frackowiak R; Marsden C D; Odin P
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.
Annals of neurology 1994;35(2):172-80.
1994: Scheffer I E; Bhatia K P; Lopes-Cendes I; Fish D R; Marsden C D; Andermann F; Andermann E; Desbiens R; Cendes F; Manson J I
Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder.
Lancet 1994;343(8896):515-7.
1994: Robbins T W; James M; Owen A M; Lange K W; Lees A J; Leigh P N; Marsden C D; Quinn N P; Summers B A
Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction.
Journal of neurology, neurosurgery, and psychiatry 1994;57(1):79-88.
1994: Dexter D T; Holley A E; Flitter W D; Slater T F; Wells F R; Daniel S E; Lees A J; Jenner P; Marsden C D
Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study.
Movement disorders : official journal of the Movement Disorder Society 1994;9(1):92-7.
1994: Schapira A H; Marsden C D
Platelet mitochondrial DNA in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1994;9(1):119-21.
1994: Dressler D; Thompson P D; Gledhill R F; Marsden C D
The syndrome of painful legs and moving toes.
Movement disorders : official journal of the Movement Disorder Society 1994;9(1):13-21.
1994: Marsden C D
Problems with long-term levodopa therapy for Parkinson's disease.
Clinical neuropharmacology 1994;17 Suppl 2():S32-44.
1994: Rothwell J C; Vidailhet M; Thompson P D; Lees A J; Marsden C D
The auditory startle response in progressive supranuclear palsy.
Journal of neural transmission. Supplementum 1994;42():43-50.
1993: Quinn N P; Marsden C D
The motor disorder of multiple system atrophy.
Journal of neurology, neurosurgery, and psychiatry 1993;56(12):1239-42.
1993: Bhatia K P; Daniel S E; Marsden C D
Familial parkinsonism with depression: a clinicopathological study.
Annals of neurology 1993;34(6):842-7.
1993: Jahanshahi M; Brown R G; Marsden C D
A comparative study of simple and choice reaction time in Parkinson's, Huntington's and cerebellar disease.
Journal of neurology, neurosurgery, and psychiatry 1993;56(11):1169-77.
1993: Kujirai T; Caramia M D; Rothwell J C; Day B L; Thompson P D; Ferbert A; Wroe S; Asselman P; Marsden C D
Corticocortical inhibition in human motor cortex.
The Journal of physiology 1993;471():501-19.
1993: Britton T C; Thompson P D; Day B L; Rothwell J C; Findley L J; Marsden C D
Modulation of postural tremors at the wrist by supramaximal electrical median nerve shocks in essential tremor, Parkinson's disease and normal subjects mimicking tremor.
Journal of neurology, neurosurgery, and psychiatry 1993;56(10):1085-9.
1993: Playford E D; Fletcher N A; Sawle G V; Marsden C D; Brooks D J
Striatal [18F]dopa uptake in familial idiopathic dystonia.
Brain : a journal of neurology 1993;116 ( Pt 5)():1191-9.
1993: Pastor M A; Day B L; Marsden C D
Vestibular induced postural responses in Parkinson's disease.
Brain : a journal of neurology 1993;116 ( Pt 5)():1177-90.
1993: de Ceballos M L; Fernandez A; Jenner P; Marsden C D
Parallel alterations in Met-enkephalin and substance P levels in medial globus pallidus in Parkinson's disease patients.
Neuroscience letters 1993;160(2):163-6.
1993: Vidailhet M; Stocchi F; Rothwell J C; Thompson P D; Day B L; Brooks D J; Marsden C D
The Bereitschaftspotential preceding simple foot movement and initiation of gait in Parkinson's disease.
Neurology 1993;43(9):1784-8.
1993: Howard R S; Greenwood R; Gawler J; Scaravilli F; Marsden C D; Harding A E
A familial disorder associated with palatal myoclonus, other brainstem signs, tetraparesis, ataxia and Rosenthal fibre formation.
Journal of neurology, neurosurgery, and psychiatry 1993;56(9):977-81.
1993: Ball J A; Lantos P L; Jackson M; Marsden C D; Scadding J W; Rossor M N
Alien hand sign in association with Alzheimer's histopathology.
Journal of neurology, neurosurgery, and psychiatry 1993;56(9):1020-3.
1993: Day B L; Steiger M J; Thompson P D; Marsden C D
Effect of vision and stance width on human body motion when standing: implications for afferent control of lateral sway.
The Journal of physiology 1993;469():479-99.
1993: Brown R G; Jahanshahi M; Marsden C D
Response choice in Parkinson's disease. The effects of uncertainty and stimulus-response compatibility.
Brain : a journal of neurology 1993;116 ( Pt 4)():869-85.
1993: Bhatia K P; Bhatt M H; Marsden C D
The causalgia-dystonia syndrome.
Brain : a journal of neurology 1993;116 ( Pt 4)():843-51.
1993: Turjanski N; Bhatia K; Burn D J; Sawle G V; Marsden C D; Brooks D J
Comparison of striatal 18F-dopa uptake in adult-onset dystonia-parkinsonism, Parkinson's disease, and dopa-responsive dystonia.
Neurology 1993;43(8):1563-8.
1993: Bain P G; Findley L J; Atchison P; Behari M; Vidailhet M; Gresty M; Rothwell J C; Thompson P D; Marsden C D
Assessing tremor severity.
Journal of neurology, neurosurgery, and psychiatry 1993;56(8):868-73.
1993: Fletcher N A; Thompson P D; Scadding J W; Marsden C D
Successful treatment of childhood onset symptomatic dystonia with levodopa.
Journal of neurology, neurosurgery, and psychiatry 1993;56(8):865-7.
1993: Rose S; Jenner P; Marsden C D
Chronic administration does not alter the pharmacokinetic profile of L-dopa in the rat.
The Journal of pharmacy and pharmacology 1993;45(8):725-30.
1993: Jenkins I H; Bain P G; Colebatch J G; Thompson P D; Findley L J; Frackowiak R S; Marsden C D; Brooks D J
A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections.
Annals of neurology 1993;34(1):82-90.
1993: Owen A M; Beksinska M; James M; Leigh P N; Summers B A; Marsden C D; Quinn N P; Sahakian B J; Robbins T W
Visuospatial memory deficits at different stages of Parkinson's disease.
Neuropsychologia 1993;31(7):627-44.
1993: Conway D; Bain P G; Warner T T; Davis M B; Findley L J; Thompson P D; Marsden C D; Harding A E
Linkage analysis with chromosome 9 markers in hereditary essential tremor.
Movement disorders : official journal of the Movement Disorder Society 1993;8(3):374-6.
1993: Bhatia K; Daniel S E; Marsden C D
Orofacial dystonia and rest tremor in a patient with normal brain pathology.
Movement disorders : official journal of the Movement Disorder Society 1993;8(3):361-2.
1993: Atchison P R; Thompson P D; Frackowiak R S; Marsden C D
The syndrome of gait ignition failure: a report of six cases.
Movement disorders : official journal of the Movement Disorder Society 1993;8(3):285-92.
1993: Warner T T; Fletcher N A; Davis M B; Ahmad F; Conway D; Feve A; Rondot P; Marsden C D; Harding A E
Linkage analysis in British and French families with idiopathic torsion dystonia.
Brain : a journal of neurology 1993;116 ( Pt 3)():739-44.
1993: Gnanalingham K K; Smith L A; Hunter A J; Jenner P; Marsden C D
Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
Synapse (New York, N.Y.) 1993;14(2):184-94.
1993: Whurr R; Lorch M; Fontana H; Brookes G; Lees A; Marsden C D
The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.
Journal of neurology, neurosurgery, and psychiatry 1993;56(5):526-30.
1993: Britton T C; Thompson P D; Day B L; Rothwell J C; Findley L J; Marsden C D
Modulation of postural wrist tremors by magnetic stimulation of the motor cortex in patients with Parkinson's disease or essential tremor and in normal subjects mimicking tremor.
Annals of neurology 1993;33(5):473-9.
1993: Thomaides T; Bleasdale-Barr K; Chaudhuri K R; Pavitt D; Marsden C D; Mathias C J
Cardiovascular and hormonal responses to liquid food challenge in idiopathic Parkinson's disease, multiple system atrophy, and pure autonomic failure.
Neurology 1993;43(5):900-4.
1993: Priori A; Bertolasi L; Rothwell J C; Day B L; Marsden C D
Some saccadic eye movements can be delayed by transcranial magnetic stimulation of the cerebral cortex in man.
Brain : a journal of neurology 1993;116 ( Pt 2)():355-67.
1993: Blunt S B; Jenner P; Marsden C D
Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine.
Movement disorders : official journal of the Movement Disorder Society 1993;8(2):129-33.
1993: Priori A; Bertolasi L; Dressler D; Rothwell J C; Day B L; Thompson P D; Marsden C D
Transcranial electric and magnetic stimulation of the leg area of the human motor cortex: single motor unit and surface EMG responses in the tibialis anterior muscle.
Electroencephalography and clinical neurophysiology 1993;89(2):131-7.
1993: Brown R G; Jahanshahi M; Marsden C D
The execution of bimanual movements in patients with Parkinson's, Huntington's and cerebellar disease.
Journal of neurology, neurosurgery, and psychiatry 1993;56(3):295-7.
1993: Bhatt M H; Obeso J A; Marsden C D
Time course of postanoxic akinetic-rigid and dystonic syndromes.
Neurology 1993;43(2):314-7.
1993: Nutt J G; Marsden C D; Thompson P D
Human walking and higher-level gait disorders, particularly in the elderly.
Neurology 1993;43(2):268-79.
1993: Ahmad F; Davis M B; Waddy H M; Oley C A; Marsden C D; Harding A E
Evidence for locus heterogeneity in autosomal dominant torsion dystonia.
Genomics 1993;15(1):9-12.
1993: Rose S; Nomoto M; Jackson E A; Gibb W R; Jaehnig P; Jenner P; Marsden C D
Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets.
European journal of pharmacology 1993;230(2):177-85.
1993: Lange K W; Wells F R; Jenner P; Marsden C D
Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.
Journal of neurochemistry 1993;60(1):197-203.
1993: Lange K W; Paul G M; Robbins T W; Marsden C D
L-dopa and frontal cognitive function in Parkinson's disease.
Advances in neurology 1993;60():475-8.
1993: Dexter D T; Sian J; Jenner P; Marsden C D
Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia.
Advances in neurology 1993;60():273-81.
1993: Brown P; Steiger M J; Thompson P D; Rothwell J C; Day B L; Salama M; Waegemans T; Marsden C D
Effectiveness of piracetam in cortical myoclonus.
Movement disorders : official journal of the Movement Disorder Society 1993;8(1):63-8.
1993: Britton T C; Day B L; Brown P; Rothwell J C; Thompson P D; Marsden C D
Postural electromyographic responses in the arm and leg following galvanic vestibular stimulation in man.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1993;94(1):143-51.
1993: Collins P; Broekkamp C L; Jenner P; Marsden C D
Effect of chronic trifluoperazine administration and subsequent withdrawal on the production and persistence of perioral behaviours in two rat strains.
Psychopharmacology 1993;112(4):437-44.
1993: Collins P; Broekkamp C L; Jenner P; Marsden C D
Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat.
Psychopharmacology 1993;112(4):428-36.
1992: Owen A M; James M; Leigh P N; Summers B A; Marsden C D; Quinn N P; Lange K W; Robbins T W
Fronto-striatal cognitive deficits at different stages of Parkinson's disease.
Brain : a journal of neurology 1992;115 ( Pt 6)():1727-51.
1992: Krige D; Carroll M T; Cooper J M; Marsden C D; Schapira A H
Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group.
Annals of neurology 1992;32(6):782-8.
1992: Jenner P; Schapira A H; Marsden C D
New insights into the cause of Parkinson's disease.
Neurology 1992;42(12):2241-50.
1992: Jahanshahi M; Brown R G; Marsden C D
The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1992;55(12):1168-76.
1992: Bhatia K; Thompson P D; Marsden C D
"Isolated" postinfectious myoclonus.
Journal of neurology, neurosurgery, and psychiatry 1992;55(11):1089-91.
1992: Thompson P D; Marsden C D
Corticobasal degeneration.
Baillière's clinical neurology 1992;1(3):677-86.
1992: Dexter D T; Ward R J; Wells F R; Daniel S E; Lees A J; Peters T J; Jenner P; Marsden C D
Alpha-tocopherol levels in brain are not altered in Parkinson's disease.
Annals of neurology 1992;32(4):591-3.
1992: Burn D J; Mark M H; Playford E D; Maraganore D M; Zimmerman T R; Duvoisin R C; Harding A E; Marsden C D; Brooks D J
Parkinson's disease in twins studied with 18F-dopa and positron emission tomography.
Neurology 1992;42(10):1894-900.
1992: Takeuchi Y; Sawada T; Blunt S; Jenner P; Marsden C D
Transplantation of embryonic mesencephalic and medullary raphe neurons to the neostriatum of rats with unilateral 6-hydroxydopamine lesions.
Brain research 1992;592(1-2):129-34.
1992: Fernandez A; de Ceballos M L; Jenner P; Marsden C D
Striatal neuropeptide levels in Parkinson's disease patients.
Neuroscience letters 1992;145(2):171-4.
1992: Anderson T J; Rivest J; Stell R; Steiger M J; Cohen H; Thompson P D; Marsden C D
Botulinum toxin treatment of spasmodic torticollis.
Journal of the Royal Society of Medicine 1992;85(9):524-9.
1992: Jones G H; Hernandez T D; Kendall D A; Marsden C A; Robbins T W
Dopaminergic and serotonergic function following isolation rearing in rats: study of behavioural responses and postmortem and in vivo neurochemistry.
Pharmacology, biochemistry, and behavior 1992;43(1):17-35.
1992: Brooks D J; Playford E D; Ibanez V; Sawle G V; Thompson P D; Findley L J; Marsden C D
Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study.
Neurology 1992;42(8):1554-60.
1992: Steiger M J; Lledo P; Quinn N P; Marsden C D; Turner P; Jenner P G
Debrisoquine hydroxylation in Parkinson's disease.
Acta neurologica Scandinavica 1992;86(2):159-64.
1992: Steiger M J; Quinn N P; Marsden C D
The clinical use of apomorphine in Parkinson's disease.
Journal of neurology 1992;239(7):389-93.
1992: Vidailhet M; Rothwell J C; Thompson P D; Lees A J; Marsden C D
The auditory startle response in the Steele-Richardson-Olszewski syndrome and Parkinson's disease.
Brain : a journal of neurology 1992;115 ( Pt 4)():1181-92.
1992: Taylor M D; De Ceballos M L; Rose S; Jenner P; Marsden C D
Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia.
European journal of pharmacology 1992;219(2):183-92.
1992: Thomaides T N; Chaudhuri K R; Maule S; Watson L; Marsden C D; Mathias C J
Growth hormone response to clonidine in central and peripheral primary autonomic failure.
Lancet 1992;340(8814):263-6.
1992: Rupniak N M; Boyce S; Steventon M J; Iversen S D; Marsden C D
Dystonia induced by combined treatment with L-dopa and MK-801 in parkinsonian monkeys.
Annals of neurology 1992;32(1):103-5.
1992: Bloom F E; Cowey A; Faull R L; Grahame-Smith D G; Gray J A; Hökfelt T; Iversen L L; Llinas R R; Marsden C D; Purpura D P
Cost of brain disorders.
Nature 1992;358(6383):184.
1992: Lang A; Quinn N; Marsden C D; Findley L; Koller W; Brin M; Fahn S
Essential tremor.
Neurology 1992;42(7):1432-4.
1992: Marsden C D
Parkinson's disease.
Postgraduate medical journal 1992;68(801):538-43.
1992: Thomas K L; Rose S; Jenner P; Marsden C D
Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Biochemical pharmacology 1992;44(1):83-91.
1992: Thomas K L; Rose S; Jenner P; Marsden C D
Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
Biochemical pharmacology 1992;44(1):73-82.
1992: Soliveri P; Brown R G; Jahanshahi M; Marsden C D
Effect of practice on performance of a skilled motor task in patients with Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1992;55(6):454-60.
1992: Blunt S B; Jenner P; Marsden C D
Autoradiographic study of striatal D1 and D2 dopamine receptors in 6-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatment with L-dopa and carbidopa.
Brain research 1992;582(2):299-311.
1992: Britton T C; Thompson P D; Day B L; Rothwell J C; Findley L J; Marsden C D
"Resetting" of postural tremors at the wrist with mechanical stretches in Parkinson's disease, essential tremor, and normal subjects mimicking tremor.
Annals of neurology 1992;31(5):507-14.
1992: Jahanshahi M; Brown R G; Marsden C D
Simple and choice reaction time and the use of advance information for motor preparation in Parkinson's disease.
Brain : a journal of neurology 1992;115 ( Pt 2)():539-64.
1992: Mann V M; Cooper J M; Krige D; Daniel S E; Schapira A H; Marsden C D
Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease.
Brain : a journal of neurology 1992;115 ( Pt 2)():333-42.
1992: Britton T C; Thompson P D; van der Kamp W; Rothwell J C; Day B L; Findley L J; Marsden C D
Primary orthostatic tremor: further observations in six cases.
Journal of neurology 1992;239(4):209-17.
1992: Jahanshahi M; Marsden C D
Psychological functioning before and after treatment of torticollis with botulinum toxin.
Journal of neurology, neurosurgery, and psychiatry 1992;55(3):229-31.
1992: Bateman D; Boughey A M; Scaravilli F; Marsden C D; Harding A E
A follow-up study of isolated cases of suspected Huntington's disease.
Annals of neurology 1992;31(3):293-8.
1992: Lange K W; Löschmann P A; Wachtel H; Horowski R; Jähnig P; Jenner P; Marsden C D
Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets.
European journal of pharmacology 1992;212(2-3):247-52.
1992: Maertens de Noordhout A; Rothwell J C; Day B L; Dressler D; Nakashima K; Thompson P D; Marsden C D
Effect of digital nerve stimuli on responses to electrical or magnetic stimulation of the human brain.
The Journal of physiology 1992;447():535-48.
1992: Brooks D J; Ibanez V; Sawle G V; Playford E D; Quinn N; Mathias C J; Lees A J; Marsden C D; Bannister R; Frackowiak R S
Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
Annals of neurology 1992;31(2):184-92.
1992: Sawle G V; Bloomfield P M; Björklund A; Brooks D J; Brundin P; Leenders K L; Lindvall O; Marsden C D; Rehncrona S; Widner H
Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.
Annals of neurology 1992;31(2):166-73.
1992: Robbins T W; James M; Lange K W; Owen A M; Quinn N P; Marsden C D
Cognitive performance in multiple system atrophy.
Brain : a journal of neurology 1992;115 Pt 1():271-91.
1992: Lange K W; Javoy-Agid F; Agid Y; Jenner P; Marsden C D
Brain muscarinic cholinergic receptors in Huntington's disease.
Journal of neurology 1992;239(2):103-4.
1992: Thompson P D; Colebatch J G; Brown P; Rothwell J C; Day B L; Obeso J A; Marsden C D
Voluntary stimulus-sensitive jerks and jumps mimicking myoclonus or pathological startle syndromes.
Movement disorders : official journal of the Movement Disorder Society 1992;7(3):257-62.
1992: Stocchi F; Ruggieri S; Carta A; Ryatt J; Quinn N; Jenner P; Marsden C D; Agnoli A
Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1992;7(3):249-56.
1992: Gibb W R; Kilford L; Marsden C D
Severe generalised dystonia associated with a mosaic pattern of striatal gliosis.
Movement disorders : official journal of the Movement Disorder Society 1992;7(3):217-23.
1992: Lange K W; Robbins T W; Marsden C D; James M; Owen A M; Paul G M
L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction.
Psychopharmacology 1992;107(2-3):394-404.
1992: Blunt S B; Jenner P; Marsden C D
Motor function, graft survival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with L-dopa and carbidopa.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1992;88(2):326-40.
1992: Steiger M J; Pires M; Scaravilli F; Quinn N P; Marsden C D
Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration.
Movement disorders : official journal of the Movement Disorder Society 1992;7(1):71-7.
1992: Meierkord H; Fish D R; Smith S J; Scott C A; Shorvon S D; Marsden C D
Is nocturnal paroxysmal dystonia a form of frontal lobe epilepsy?
Movement disorders : official journal of the Movement Disorder Society 1992;7(1):38-42.
1992: Dexter D T; Jenner P; Schapira A H; Marsden C D
Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group.
Annals of neurology 1992;32 Suppl():S94-100.
1992: Jenner P; Dexter D T; Sian J; Schapira A H; Marsden C D
Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group.
Annals of neurology 1992;32 Suppl():S82-7.
1992: Schapira A H; Mann V M; Cooper J M; Krige D; Jenner P J; Marsden C D
Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group.
Annals of neurology 1992;32 Suppl():S116-24.
1992: Ferbert A; Priori A; Rothwell J C; Day B L; Colebatch J G; Marsden C D
Interhemispheric inhibition of the human motor cortex.
The Journal of physiology 1992;453():525-46.
1992: Löschmann P A; Smith L A; Lange K W; Jähnig P; Jenner P; Marsden C D
Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to MPTP-treated common marmosets.
Psychopharmacology 1992;109(1-2):49-56.
1991: Jahanshahi M; Sartory G; Marsden C D
EMG biofeedback treatment of torticollis: a controlled outcome study.
Biofeedback and self-regulation 1991;16(4):413-48.
1991: Brown P; Day B L; Rothwell J C; Thompson P D; Marsden C D
Intrahemispheric and interhemispheric spread of cerebral cortical myoclonic activity and its relevance to epilepsy.
Brain : a journal of neurology 1991;114 ( Pt 5)():2333-51.
1991: Brown P; Day B L; Rothwell J C; Thompson P D; Marsden C D
The effect of posture on the normal and pathological auditory startle reflex.
Journal of neurology, neurosurgery, and psychiatry 1991;54(10):892-7.
1991: Thompson P D; Day B L; Rothwell J C; Dressler D; Maertens de Noordhout A; Marsden C D
Further observations on the facilitation of muscle responses to cortical stimulation by voluntary contraction.
Electroencephalography and clinical neurophysiology 1991;81(5):397-402.
1991: Takeuchi Y; Sawada T; Blunt S; Jenner P; Marsden C D
Effects of 6-hydroxydopamine lesions of the nigrostriatal pathway on striatal serotonin innervation in adult rats.
Brain research 1991;562(2):301-5.
1991: Ugawa Y; Day B L; Rothwell J C; Thompson P D; Merton P A; Marsden C D
Modulation of motor cortical excitability by electrical stimulation over the cerebellum in man.
The Journal of physiology 1991;441():57-72.
1991: Fletcher N A; Harding A E; Marsden C D
The relationship between trauma and idiopathic torsion dystonia.
Journal of neurology, neurosurgery, and psychiatry 1991;54(8):713-7.
1991: Brooks D J; Ibanez V; Playford E D; Sawle G V; Leigh P N; Kocen R S; Harding A E; Marsden C D
Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: a positron emission tomographic study.
Annals of neurology 1991;30(2):166-71.
1991: Brown P; Rothwell J C; Thompson P D; Britton T C; Day B L; Marsden C D
The hyperekplexias and their relationship to the normal startle reflex.
Brain : a journal of neurology 1991;114 ( Pt 4)():1903-28.
1991: Brown P; Rothwell J C; Thompson P D; Britton T C; Day B L; Marsden C D
New observations on the normal auditory startle reflex in man.
Brain : a journal of neurology 1991;114 ( Pt 4)():1891-902.
1991: Dexter D T; Carayon A; Javoy-Agid F; Agid Y; Wells F R; Daniel S E; Lees A J; Jenner P; Marsden C D
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
Brain : a journal of neurology 1991;114 ( Pt 4)():1953-75.
1991: Sawle G V; Leenders K L; Brooks D J; Harwood G; Lees A J; Frackowiak R S; Marsden C D
Dopa-responsive dystonia: [18F]dopa positron emission tomography.
Annals of neurology 1991;30(1):24-30.
1991: Thompson P D; Day B L; Crockard H A; Calder I; Murray N M; Rothwell J C; Marsden C D
Intra-operative recording of motor tract potentials at the cervico-medullary junction following scalp electrical and magnetic stimulation of the motor cortex.
Journal of neurology, neurosurgery, and psychiatry 1991;54(7):618-23.
1991: Walker M J; Jenner P; Marsden C D
A redox reaction between MPP+ and MPDP+ to produce superoxide radicals does not impair mitochondrial function.
Biochemical pharmacology 1991;42(4):913-9.
1991: Steiger M J; Stocchi F; Carta A; Ruggieri S; Agnoli A; Quinn N P; Marsden C D
The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's disease.
Clinical neuropharmacology 1991;14(3):241-4.
1991: Takeuchi Y; Sawada T; Blunt S; Jenner P; Marsden C D
Serotonergic sprouting in the neostriatum after intrastriatal transplantation of fetal ventral mesencephalon.
Brain research 1991;551(1-2):171-7.
1991: Rose S; Jenner P; Marsden C D
Peripheral pharmacokinetic handling and metabolism of L-dopa in the rat: the effect of route of administration and carbidopa pretreatment.
The Journal of pharmacy and pharmacology 1991;43(5):325-30.
1991: Taylor M D; de Ceballos M L; Jenner P; Marsden C D
Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the rat.
Biochemical pharmacology 1991;41(9):1385-91.
1991: Lange K W; Wells F R; Rossor M N; Jenner P; Marsden C D
Cortical nicotinic receptors in Alzheimer's disease and Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1991;54(4):373-4.
1991: Ugawa Y; Rothwell J C; Day B L; Thompson P D; Marsden C D
Percutaneous electrical stimulation of corticospinal pathways at the level of the pyramidal decussation in humans.
Annals of neurology 1991;29(4):418-27.
1991: Jones G H; Marsden C A; Robbins T W
Behavioural rigidity and rule-learning deficits following isolation-rearing in the rat: neurochemical correlates.
Behavioural brain research 1991;43(1):35-50.
1991: Rothwell J C; Thompson P D; Day B L; Boyd S; Marsden C D
Stimulation of the human motor cortex through the scalp.
Experimental physiology 1991;76(2):159-200.
1991: Waddy H M; Fletcher N A; Harding A E; Marsden C D
A genetic study of idiopathic focal dystonias.
Annals of neurology 1991;29(3):320-4.
1991: Fish D R; Sawyers D; Smith S J; Allen P J; Murray N M; Marsden C D
Motor inhibition from the brainstem is normal in torsion dystonia during REM sleep.
Journal of neurology, neurosurgery, and psychiatry 1991;54(2):140-4.
1991: Hallett M; Berardelli A; Matheson J; Rothwell J; Marsden C D
Physiological analysis of simple rapid movements in patients with cerebellar deficits.
Journal of neurology, neurosurgery, and psychiatry 1991;54(2):124-33.
1991: Brown R G; Marsden C D
Dual task performance and processing resources in normal subjects and patients with Parkinson's disease.
Brain : a journal of neurology 1991;114 ( Pt 1A)():215-31.
1991: Brown P; Thompson P D; Rothwell J C; Day B L; Marsden C D
Axial myoclonus of propriospinal origin.
Brain : a journal of neurology 1991;114 ( Pt 1A)():197-214.
1991: Widner H; Brundin P; Rehncrona S; Gustavii B; Frackowiak R; Leenders K L; Sawle G; Rothwell J C; Marsden C D; Björklund A
Transplanted allogeneic fetal dopamine neurons survive and improve motor function in idiopathic Parkinson's disease.
Transplantation proceedings 1991;23(1 Pt 1):793-5.
1991: Sawle G V; Brooks D J; Marsden C D; Frackowiak R S
Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography.
Brain : a journal of neurology 1991;114 ( Pt 1B)():541-56.
1991: Nygaard T G; Marsden C D; Fahn S
Dopa-responsive dystonia: long-term treatment response and prognosis.
Neurology 1991;41(2 ( Pt 1)):174-81.
1991: Day B L; Riescher H; Struppler A; Rothwell J C; Marsden C D
Changes in the response to magnetic and electrical stimulation of the motor cortex following muscle stretch in man.
The Journal of physiology 1991;433():41-57.
1991: Fish D R; Sawyers D; Allen P J; Blackie J D; Lees A J; Marsden C D
The effect of sleep on the dyskinetic movements of Parkinson's disease, Gilles de la Tourette syndrome, Huntington's disease, and torsion dystonia.
Archives of neurology 1991;48(2):210-4.
1991: van der Kamp W; Maertens de Noordhout A; Thompson P D; Rothwell J C; Day B L; Marsden C D
Correlation of phasic muscle strength and corticomotoneuron conduction time in multiple sclerosis.
Annals of neurology 1991;29(1):6-12.
1991: Nair K R; Bhaskaran R; Marsden C D
Essential tremor associated with paroxysmal kinesigenic dystonia.
Movement disorders : official journal of the Movement Disorder Society 1991;6(1):92-3.
1991: Steiger M J; Quinn N P; Marsden C D
Sickness due to levodopa-induced neck dyskinesias in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1991;6(1):91-2.
1991: Steiger M J; Quinn N P; Toone B; Marsden C D
Off-period screaming accompanying motor fluctuations in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1991;6(1):89-90.
1991: Duncan J S; Brown P; Marsden C D
Progressive myoclonus and histidinaemia.
Movement disorders : official journal of the Movement Disorder Society 1991;6(1):87-9.
1991: Hughes A J; Lees A J; Marsden C D
Paroxysmal dystonic head tremor.
Movement disorders : official journal of the Movement Disorder Society 1991;6(1):85-6.
1991: Brown P; Thompson P D; Rothwell J C; Day B L; Marsden C D
A therapeutic trial of milacemide in myoclonus and the stiff-person syndrome.
Movement disorders : official journal of the Movement Disorder Society 1991;6(1):73-5.
1991: Rivest J; Lees A J; Marsden C D
Writer's cramp: treatment with botulinum toxin injections.
Movement disorders : official journal of the Movement Disorder Society 1991;6(1):55-9.
1991: Brown P; Thompson P D; Rothwell J C; Day B L; Marsden C D
Paroxysmal axial spasms of spinal origin.
Movement disorders : official journal of the Movement Disorder Society 1991;6(1):43-8.
1991: Maraganore D M; Harding A E; Marsden C D
A clinical and genetic study of familial Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1991;6(3):205-11.
1991: Brown P; Thompson P D; Rothwell J C; Day B L; Marsden C D
A case of postanoxic encephalopathy with cortical action and brainstem reticular reflex myoclonus.
Movement disorders : official journal of the Movement Disorder Society 1991;6(2):139-44.
1991: Blunt S; Jenner P; Marsden C D
The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts.
Neuroscience 1991;40(2):453-64.
1991: Löschmann P A; Lange K W; Kunow M; Rettig K J; Jähnig P; Honoré T; Turski L; Wachtel H; Jenner P; Marsden C D
Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's disease.
Journal of neural transmission. Parkinson's disease and dementia section 1991;3(3):203-13.
1991: Vecht C J; Meerwaldt J D; Lees A J; Marsden C D; Fahn S
What is it? Case 2, 1991: unusual tremor, myoclonus, and a limping gait.
Movement disorders : official journal of the Movement Disorder Society 1991;6(4):371-5.
1991: Maraganore D M; Lees A J; Marsden C D
Complex stereotypies after right putaminal infarction: a case report.
Movement disorders : official journal of the Movement Disorder Society 1991;6(4):358-61.
1991: Fletcher N A; Harding A E; Marsden C D
Intrafamilial correlation in idiopathic torsion dystonia.
Movement disorders : official journal of the Movement Disorder Society 1991;6(4):310-4.
1991: Fletcher N A; Harding A E; Marsden C D
A case-control study of idiopathic torsion dystonia.
Movement disorders : official journal of the Movement Disorder Society 1991;6(4):304-9.
1991: Taylor M D; de Ceballos M L; Rose S; Chong P N; Jenner P; Marsden C D
Neuropeptide levels in the basal ganglia of aged common marmosets following prolonged treatment with MPTP.
Journal of neural transmission. Parkinson's disease and dementia section 1991;3(2):99-108.
1991: Löschmann P A; Smith L A; Lange K W; Jaehnig P; Jenner P; Marsden C D
Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosets.
Psychopharmacology 1991;105(3):303-9.
1991: Blunt S B; Jenner P; Marsden C D
The effect of L-dopa and carbidopa treatment on the survival of rat fetal dopamine grafts assessed by tyrosine hydroxylase immunohistochemistry and [3H]mazindol autoradiography.
Neuroscience 1991;43(1):95-110.
1991: Collins P; Broekkamp C L; Jenner P; Marsden C D
Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation.
Psychopharmacology 1991;103(4):503-12.
1990: Colebatch J G; Rothwell J C; Day B L; Thompson P D; Marsden C D
Cortical outflow to proximal arm muscles in man.
Brain : a journal of neurology 1990;113 ( Pt 6)():1843-56.
1990: Sawle G V; Colebatch J G; Shah A; Brooks D J; Marsden C D; Frackowiak R S
Striatal function in normal aging: implications for Parkinson's disease.
Annals of neurology 1990;28(6):799-804.
1990: Leenders K L; Salmon E P; Tyrrell P; Perani D; Brooks D J; Sager H; Jones T; Marsden C D; Frackowiak R S
The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.
Archives of neurology 1990;47(12):1290-8.
1990: Schapira A H; Mann V M; Cooper J M; Dexter D; Daniel S E; Jenner P; Clark J B; Marsden C D
Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.
Journal of neurochemistry 1990;55(6):2142-5.
1990: Rivest J; Quinn N; Marsden C D
Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Neurology 1990;40(10):1571-8.
1990: Brooks D J; Ibanez V; Sawle G V; Quinn N; Lees A J; Mathias C J; Bannister R; Marsden C D; Frackowiak R S
Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Annals of neurology 1990;28(4):547-55.
1990: Brooks D J; Salmon E P; Mathias C J; Quinn N; Leenders K L; Bannister R; Marsden C D; Frackowiak R S
The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.
Brain : a journal of neurology 1990;113 ( Pt 5)():1539-52.
1990: Marsden C D; Harding A E; Obeso J A; Lu C S
Progressive myoclonic ataxia (the Ramsay Hunt syndrome).
Archives of neurology 1990;47(10):1121-5.
1990: Colebatch J G; Findley L J; Frackowiak R S; Marsden C D; Brooks D J
Preliminary report: activation of the cerebellum in essential tremor.
Lancet 1990;336(8722):1028-30.
1990: Dexter D T; Carayon A; Vidailhet M; Ruberg M; Agid F; Agid Y; Lees A J; Wells F R; Jenner P; Marsden C D
Decreased ferritin levels in brain in Parkinson's disease.
Journal of neurochemistry 1990;55(1):16-20.
1990: Nakashima K; Rothwell J C; Day B L; Thompson P D; Marsden C D
Cutaneous effects on presynaptic inhibition of flexor Ia afferents in the human forearm.
The Journal of physiology 1990;426():369-80.
1990: Stell R; Bronstein A M; Gresty M; Buckwell D; Marsden C D
Saccadic function in spasmodic torticollis.
Journal of neurology, neurosurgery, and psychiatry 1990;53(6):496-501.
1990: Brown R G; Jahanshahi M; Quinn N; Marsden C D
Sexual function in patients with Parkinson's disease and their partners.
Journal of neurology, neurosurgery, and psychiatry 1990;53(6):480-6.
1990: Jahanshahi M; Marion M H; Marsden C D
Natural history of adult-onset idiopathic torticollis.
Archives of neurology 1990;47(5):548-52.
1990: Rose S; Nomoto M; Jackson E A; Gibb W R; Jenner P; Marsden C D
1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) is less neurotoxic than MPTP in the common marmoset.
European journal of pharmacology 1990;181(1-2):97-103.
1990: Nakashima K; Rothwell J C; Thompson P D; Day B L; Berardelli A; Agostino R; Artieda J; Papas S M; Obeso J A; Marsden C D
The blink reflex in patients with idiopathic torsion dystonia.
Archives of neurology 1990;47(4):413-6.
1990: Fletcher N A; Harding A E; Marsden C D
A genetic study of idiopathic torsion dystonia in the United Kingdom.
Brain : a journal of neurology 1990;113 ( Pt 2)():379-95.
1990: Marsden C D; Sheehy M P
Writer's cramp.
Trends in neurosciences 1990;13(4):148-53.
1990: Marsden C D
Parkinson's disease.
Lancet 1990;335(8695):948-52.
1990: Schapira A H; Cooper J M; Dexter D; Clark J B; Jenner P; Marsden C D
Mitochondrial complex I deficiency in Parkinson's disease.
Journal of neurochemistry 1990;54(3):823-7.
1990: Fish D R; Allen P J; Sawyers D; Marsden C D
Sleep spindles in torsion dystonia.
Archives of neurology 1990;47(2):216-8.
1990: Lindvall O; Brundin P; Widner H; Rehncrona S; Gustavii B; Frackowiak R; Leenders K L; Sawle G; Rothwell J C; Marsden C D
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease.
Science (New York, N.Y.) 1990;247(4942):574-7.
1990: Coleman R J; Quinn N P; Traub M; Marsden C D
Nasogastric and intravenous infusions of (+)-4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1990;53(2):102-5.
1990: Raisman-Vozari R; Girault J A; Moussaoui S; Feuerstein C; Jenner P; Marsden C D; Agid Y
Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man.
Brain research 1990;507(1):45-50.
1990: Marsden C D; Quinn N P
The dystonias.
BMJ (Clinical research ed.) 1990;300(6718):139-44.
1990: Brown R G; Marsden C D
Cognitive function in Parkinson's disease: from description to theory.
Trends in neurosciences 1990;13(1):21-9.
1990: Winer J B; Fish D R; Sawyers D; Marsden C D
A movement disorder as a presenting feature of recurrent hypoglycaemia.
Movement disorders : official journal of the Movement Disorder Society 1990;5(2):176-7.
1990: Truong D D; Harding A E; Scaravilli F; Smith S J; Morgan-Hughes J A; Marsden C D
Movement disorders in mitochondrial myopathies. A study of nine cases with two autopsy studies.
Movement disorders : official journal of the Movement Disorder Society 1990;5(2):109-17.
1990: Grandas F; Quinn N; Elston J; Marsden C D
The cause of blepharospasm is unknown in most cases.
Movement disorders : official journal of the Movement Disorder Society 1990;5(1):89.
1990: Rivest J; Marsden C D
Trunk and head tremor as isolated manifestations of dystonia.
Movement disorders : official journal of the Movement Disorder Society 1990;5(1):60-5.
1990: Canavan A G; Passingham R E; Marsden C D; Quinn N; Wyke M; Polkey C E
Prism adaptation and other tasks involving spatial abilities in patients with Parkinson's disease, patients with frontal lobe lesions and patients with unilateral temporal lobectomies.
Neuropsychologia 1990;28(9):969-84.
1990: Rivest J; Quinn N; Gibbs J; Marsden C D
Unilateral abolition of extrapyramidal rigidity after ipsilateral cerebellar infarction.
Movement disorders : official journal of the Movement Disorder Society 1990;5(4):328-30.
1990: Jones G H; Marsden C A; Robbins T W
Increased sensitivity to amphetamine and reward-related stimuli following social isolation in rats: possible disruption of dopamine-dependent mechanisms of the nucleus accumbens.
Psychopharmacology 1990;102(3):364-72.
1990: Gibb W R; Luthert P J; Marsden C D
Clinical and pathological features of corticobasal degeneration.
Advances in neurology 1990;53():51-4.
1990: Iliceto G; Thompson P D; Day B L; Rothwell J C; Lees A J; Marsden C D
Diaphragmatic flutter, the moving umbilicus syndrome, and "belly dancer's" dyskinesia.
Movement disorders : official journal of the Movement Disorder Society 1990;5(1):15-22.
1990: Annett L E; Dunnett S B; Martel F L; Rogers D C; Ridley R M; Baker H F; Marsden C D
A functional assessment of embryonic dopaminergic grafts in the marmoset.
Progress in brain research 1990;82():535-42.
1990: Blunt S B; Jenner P; Marsden C D
The effect of L-dopa and carbidopa on behavioural recovery produced by ventral mesencephalic grafts in rats.
Progress in brain research 1990;82():493-8.
1990: Schapira A H; Holt I J; Sweeney M; Harding A E; Jenner P; Marsden C D
Mitochondrial DNA analysis in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1990;5(4):294-7.
1990: Davis A; Jenner P; Marsden C D
Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
Psychopharmacology 1990;100(1):19-26.
1990: de Ceballos M L; Jenner P; Marsden C D
Increased [Met]enkephalin and decreased substance P in spinal cord following thermal injury to one limb.
Neuroscience 1990;36(3):731-6.
1989: Lange K W; Wells F R; Rossor M N; Jenner P; Marsden C D
Cortical muscarinic receptors in demented patients with Alzheimer's disease or Parkinson's disease.
British journal of pharmacology 1989;98 Suppl():817P.
1989: Rose S; Thomas K; Jenner P; Marsden C D
Fluctuations in response to L-dopa in Parkinson's disease may be explained by changes in striatal dopamine turnover.
British journal of pharmacology 1989;98 Suppl():816P.
1989: Collins P; Broekkamp C L; Jenner P; Marsden C D
D1 or D2 receptor-induced purposeless chewing in rats is differentially modulated by cholinergic drugs.
British journal of pharmacology 1989;98 Suppl():815P.
1989: Rose S; Nomoto M; Jenner P; Marsden C D
Transient depletion of nucleus accumbens dopamine content may contribute to initial akinesia induced by MPTP in common marmosets.
Biochemical pharmacology 1989;38(21):3677-81.
1989: Lange K W; Wells F R; Rossor M N; Jenner P; Marsden C D
Brain muscarinic receptors in Alzheimer's and Parkinson's diseases.
Lancet 1989;2(8674):1279.
1989: Rose S; Nomoto M; Jackson E A; Gibb W R; Jenner P; Marsden C D
Treatment with a selective MAO B inhibitor prevents loss of dopamine in the nucleus accumbens of MPTP-treated common marmosets.
Neuropharmacology 1989;28(11):1211-6.
1989: Eardley I; Quinn N P; Fowler C J; Kirby R S; Parkhouse H F; Marsden C D; Bannister R
The value of urethral sphincter electromyography in the differential diagnosis of parkinsonism.
British journal of urology 1989;64(4):360-2.
1989: Nakashima K; Thompson P D; Rothwell J C; Day B L; Stell R; Marsden C D
An exteroceptive reflex in the sternocleidomastoid muscle produced by electrical stimulation of the supraorbital nerve in normal subjects and patients with spasmodic torticollis.
Neurology 1989;39(10):1354-8.
1989: Stell R; Thompson P D; Marsden C D
Botulinum toxin in torticollis.
Neurology 1989;39(10):1403-4.
1989: Jahanshahi M; Marsden C D
Treatments for torticollis.
Journal of neurology, neurosurgery, and psychiatry 1989;52(10):1212.
1989: Harding A E; Thompson P D; Kocen R S; Batchelor J R; Davey N; Marsden C D
Plasma exchange and immunosuppression in the stiff man syndrome.
Lancet 1989;2(8668):915.
1989: Ueki A; Chong P N; Albanese A; Rose S; Chivers J K; Jenner P; Marsden C D
Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxin.
Neuropharmacology 1989;28(10):1089-97.
1989: Gibb W R; Luthert P J; Marsden C D
Corticobasal degeneration.
Brain : a journal of neurology 1989;112 ( Pt 5)():1171-92.
1989: van der Kamp W; Berardelli A; Rothwell J C; Thompson P D; Day B L; Marsden C D
Rapid elbow movements in patients with torsion dystonia.
Journal of neurology, neurosurgery, and psychiatry 1989;52(9):1043-9.
1989: Ugawa Y; Rothwell J C; Day B L; Thompson P D; Marsden C D
Magnetic stimulation over the spinal enlargements.
Journal of neurology, neurosurgery, and psychiatry 1989;52(9):1025-32.
1989: Saggu H; Cooksey J; Dexter D; Wells F R; Lees A; Jenner P; Marsden C D
A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra.
Journal of neurochemistry 1989;53(3):692-7.
1989: Brown R G; MacCarthy B; Jahanshahi M; Marsden C D
Accuracy of self-reported disability in patients with parkinsonism.
Archives of neurology 1989;46(9):955-9.
1989: Löschmann P A; Chong P N; Nomoto M; Tepper P G; Horn A S; Jenner P; Marsden C D
Stereoselective reversal of MPTP-induced parkinsonism in the marmoset after dermal application of N-0437.
European journal of pharmacology 1989;166(3):373-80.
1989: Grandas F; Elston J; Quinn N; Marsden C D
[Pharmacologic, surgical and infiltration of botulin toxin treatment in blepharospasm]
Neurología (Barcelona, Spain) 1989;4(6):194-9.
1989: Rose S; Nomoto M; Kelly E; Kilpatrick G; Jenner P; Marsden C D
Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP.
Neuroscience letters 1989;101(3):305-10.
1989: Nakashima K; Rothwell J C; Day B L; Thompson P D; Shannon K; Marsden C D
Reciprocal inhibition between forearm muscles in patients with writer's cramp and other occupational cramps, symptomatic hemidystonia and hemiparesis due to stroke.
Brain : a journal of neurology 1989;112 ( Pt 3)():681-97.
1989: Day B L; Rothwell J C; Thompson P D; Maertens de Noordhout A; Nakashima K; Shannon K; Marsden C D
Delay in the execution of voluntary movement by electrical or magnetic brain stimulation in intact man. Evidence for the storage of motor programs in the brain.
Brain : a journal of neurology 1989;112 ( Pt 3)():649-63.
1989: Dexter D T; Wells F R; Lees A J; Agid F; Agid Y; Jenner P; Marsden C D
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.
Journal of neurochemistry 1989;52(6):1830-6.
1989: Jackson E A; Jenner P; Marsden C D
Behavioural and morphological changes following treatment with GM-1 ganglioside of rats with an electrolytic lesion of the substantia nigra.
Neuropharmacology 1989;28(6):543-55.
1989: Schapira A H; Cooper J M; Dexter D; Jenner P; Clark J B; Marsden C D
Mitochondrial complex I deficiency in Parkinson's disease.
Lancet 1989;1(8649):1269.
1989: Obeso J A; Artieda J; Rothwell J C; Day B; Thompson P; Marsden C D
The treatment of severe action myoclonus.
Brain : a journal of neurology 1989;112 ( Pt 3)():765-77.
1989: Day B L; Dressler D; Maertens de Noordhout A; Marsden C D; Nakashima K; Rothwell J C; Thompson P D
Electric and magnetic stimulation of human motor cortex: surface EMG and single motor unit responses.
The Journal of physiology 1989;412():449-73.
1989: Marsden C D
The work of neurologists.
Journal of neurology, neurosurgery, and psychiatry 1989;52(4):429.
1989: Stewart B R; Jenner P; Marsden C D
Induction of purposeless chewing behaviour in rats by 5-HT agonist drugs.
European journal of pharmacology 1989;162(1):101-7.
1989: Dick J P; Rothwell J C; Day B L; Cantello R; Buruma O; Gioux M; Benecke R; Berardelli A; Thompson P D; Marsden C D
The Bereitschaftspotential is abnormal in Parkinson's disease.
Brain : a journal of neurology 1989;112 ( Pt 1)():233-44.
1989: Dexter D T; Carter C J; Wells F R; Javoy-Agid F; Agid Y; Lees A; Jenner P; Marsden C D
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.
Journal of neurochemistry 1989;52(2):381-9.
1989: Chivers J K; Reavill C; Jenner P; Marsden C D
Definition of the in-vivo binding of [3H]spiperone in rat brain using substituted benzamide drugs.
The Journal of pharmacy and pharmacology 1989;41(2):106-11.
1989: Temlett J A; Quinn N P; Marsden C D; Lataste X; Jaton A L
The antiparkinsonian activity of CQA 206-291, a new D2 dopamine receptor agonist.
Clinical neuropharmacology 1989;12(1):55-9.
1989: Coleman R J; Temlett J A; Quinn N P; Stahl S M; Marsden C D
A strategy for measuring the therapeutic properties of new antiparkinsonian drugs, such as +PHNO, in patients with on-off fluctuations.
Clinical neuropharmacology 1989;12(1):37-45.
1989: Jones G H; Robbins T W; Marsden C A
Isolation-rearing retards the acquisition of schedule-induced polydipsia in rats.
Physiology & behavior 1989;45(1):71-7.
1989: Stell R; Bronstein A M; Marsden C D
Vestibulo-ocular abnormalities in spasmodic torticollis before and after botulinum toxin injections.
Journal of neurology, neurosurgery, and psychiatry 1989;52(1):57-62.
1989: Brooks D J; Luthert P; Gadian D; Marsden C D
Does signal-attenuation on high-field T2-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels.
Journal of neurology, neurosurgery, and psychiatry 1989;52(1):108-11.
1989: Fletcher N A; Holt I J; Harding A E; Nygaard T G; Mallet J; Marsden C D
Tyrosine hydroxylase and levodopa responsive dystonia.
Journal of neurology, neurosurgery, and psychiatry 1989;52(1):112-4.
1989: Canavan A G; Passingham R E; Marsden C D; Quinn N; Wyke M; Polkey C E
The performance on learning tasks of patients in the early stages of Parkinson's disease.
Neuropsychologia 1989;27(2):141-56.
1989: Canavan A G; Passingham R E; Marsden C D; Quinn N; Wyke M; Polkey C E
Sequence ability in parkinsonians, patients with frontal lobe lesions and patients who have undergone unilateral temporal lobectomies.
Neuropsychologia 1989;27(6):787-98.
1989: Dexter D T; Jenner P; Marsden C D
Oxyferriscorbone elevates the total iron content of blood but not brain.
Movement disorders : official journal of the Movement Disorder Society 1989;4(2):176-82.
1989: Coleman R J; Lange K W; Quinn N P; Loper A E; Bondi J V; Hichens M; Stahl S M; Marsden C D
The antiparkinsonian actions and pharmacokinetics of transdermal (+)-4-propyl-9-hydroxynaphthoxazine (+PHNO): preliminary results.
Movement disorders : official journal of the Movement Disorder Society 1989;4(2):129-38.
1989: Marsden C D
Slowness of movement in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1989;4 Suppl 1():S26-37.
1989: Maertens de Noordhout A; Rothwell J C; Day B L; Thompson P D; Delwaide P J; Marsden C D
[Percutaneous electric and magnetic stimulation of the motor cortex in man. Physiological aspects and clinical applications]
Revue neurologique 1989;145(1):1-15.
1989: Rothwell J C; Day B L; Thompson P D; Marsden C D
Interruption of motor programmes by electrical or magnetic brain stimulation in man.
Progress in brain research 1989;80():467-72; discussion 465-6.
1989: Temlett J A; Quinn N P; Jenner P G; Marsden C D; Pourcher E; Bonnet A M; Agid Y; Markstein R; Lataste X
Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1989;4(3):261-5.
1989: Quinn N P; Luthert P; Honavar M; Marsden C D
Pure akinesia due to lewy body Parkinson's disease: a case with pathology.
Movement disorders : official journal of the Movement Disorder Society 1989;4(1):85-9.
1989: Stewart B R; Jenner P; Marsden C D
Assessment of the muscarinic receptor subtype involved in the mediation of pilocarpine-induced purposeless chewing behaviour.
Psychopharmacology 1989;97(2):228-34.
1989: Marsden C D; Obeso J A
The Ramsay Hunt syndrome is a useful clinical entity.
Movement disorders : official journal of the Movement Disorder Society 1989;4(1):6-12.
1989: Gibb W R; Terruli M; Lees A J; Jenner P; Marsden C D
The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Movement disorders : official journal of the Movement Disorder Society 1989;4(1):53-74.
1988: Obeso J A; Artieda J; Quinn N; Rothwell J C; Luquin M R; Vaamonde J; Marsden C D
Piracetam in the treatment of different types of myoclonus.
Clinical neuropharmacology 1988;11(6):529-36.
1988: Jahanshahi M; Marsden C D
Depression in torticollis: a controlled study.
Psychological medicine 1988;18(4):925-33.
1988: Temlett J A; Chong P N; Oertel W H; Jenner P; Marsden C D
The D-1 dopamine receptor partial agonist, CY 208-243, exhibits antiparkinsonian activity in the MPTP-treated marmoset.
European journal of pharmacology 1988;156(2):197-206.
1988: Nomoto M; Jenner P; Marsden C D
The D1 agonist SKF 38393 inhibits the antiparkinsonian activity of the D2 agonist LY 171555 in the MPTP-treated marmoset.
Neuroscience letters 1988;93(2-3):275-80.
1988: Taquet H; Nomoto M; Rose S; Jenner P; Javoy-Agid F; Mauborgne A; Benoliel J J; Marsden C D; Legrand J C; Agid Y
Levels of Met-enkephalin, Leu-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment.
Neuropeptides 1988;12(3):105-10.
1988: Stell R; Coleman R; Thompson P; Marsden C D
Botulinum toxin treatment of spasmodic torticollis.
BMJ (Clinical research ed.) 1988;297(6648):616.
1988: Chivers J K; Reavill C; Jenner P; Marsden C D
Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation.
The Journal of pharmacy and pharmacology 1988;40(9):613-9.
1988: Uney J B; Leigh P N; Marsden C D; Lees A; Anderton B H
Stereotaxic injection of kainic acid into the striatum of rats induces synthesis of mRNA for heat shock protein 70.
FEBS letters 1988;235(1-2):215-8.
1988: Horton R W; Lowther S; Chivers J; Jenner P; Marsden C D; Testa B
The interaction of substituted benzamides with brain benzodiazepine binding sites in vitro.
British journal of pharmacology 1988;94(4):1234-40.
1988: Stell R; Thompson P D; Marsden C D
Botulinum toxin in spasmodic torticollis.
Journal of neurology, neurosurgery, and psychiatry 1988;51(7):920-3.
1988: Aubby D; Saggu H K; Jenner P; Quinn N P; Harding A E; Marsden C D
Leukocyte glutamate dehydrogenase activity in patients with degenerative neurological disorders.
Journal of neurology, neurosurgery, and psychiatry 1988;51(7):893-902.
1988: Willoughby J; Glover V; Sandler M; Albanese A; Jenner P; Marsden C D
Monoamine oxidase activity and distribution in marmoset brain: implications for MPTP toxicity.
Neuroscience letters 1988;90(1-2):100-6.
1988: Roberts F P; Lucas E G; Marsden C D; Trauer T
Near-pure xylene causing reversible neuropsychiatric disturbance.
Lancet 1988;2(8605):273.
1988: Grandas F; Elston J; Quinn N; Marsden C D
Blepharospasm: a review of 264 patients.
Journal of neurology, neurosurgery, and psychiatry 1988;51(6):767-72.
1988: Quinn N P; Ring H; Honavar M; Marsden C D
Contractures of the extremities in parkinsonian subjects: a report of three cases with a possible association with bromocriptine treatment.
Clinical neuropharmacology 1988;11(3):268-77.
1988: Chivers J K; Gommeren W; Leysen J E; Jenner P; Marsden C D
Comparison of the in-vitro receptor selectivity of substituted benzamide drugs for brain neurotransmitter receptors.
The Journal of pharmacy and pharmacology 1988;40(6):415-21.
1988: Jahanshahi M; Marsden C D
Personality in torticollis: a controlled study.
Psychological medicine 1988;18(2):375-87.
1988: Brown R G; Marsden C D
'Subcortical dementia': the neuropsychological evidence.
Neuroscience 1988;25(2):363-87.
1988: Hong M; Roots E J; Jenner P; Marsden C D
The effect of long-term treatment with amine-depleting drugs or chlorpromazine on alpha-adrenoreceptors and 5-HT2 receptors in the brain of the rat.
Neuropharmacology 1988;27(5):519-27.
1988: Brown R G; Marsden C D
Internal versus external cues and the control of attention in Parkinson's disease.
Brain : a journal of neurology 1988;111 ( Pt 2)():323-45.
1988: Gotham A M; Brown R G; Marsden C D
'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa.
Brain : a journal of neurology 1988;111 ( Pt 2)():299-321.
1988: Albanese A; Jenner P; Marsden C D; Stephenson J D
Bladder hyperreflexia induced in marmosets by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Neuroscience letters 1988;87(1-2):46-50.
1988: Thompson P D; Berardelli A; Rothwell J C; Day B L; Dick J P; Benecke R; Marsden C D
The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement.
Brain : a journal of neurology 1988;111 ( Pt 2)():223-44.
1988: Brown R G; MacCarthy B; Gotham A M; Der G J; Marsden C D
Depression and disability in Parkinson's disease: a follow-up of 132 cases.
Psychological medicine 1988;18(1):49-55.
1988: Maertens de Noordhout A; Rothwell J C; Thompson P D; Day B L; Marsden C D
Percutaneous electrical stimulation of lumbosacral roots in man.
Journal of neurology, neurosurgery, and psychiatry 1988;51(2):174-81.
1988: Berardelli A; Rothwell J C; Day B L; Marsden C D
The pathophysiology of cranial dystonia.
Advances in neurology 1988;50():525-35.
1988: Sheehy M P; Rothwell J C; Marsden C D
Writer's cramp.
Advances in neurology 1988;50():457-72.
1988: Quinn N P; Rothwell J C; Thompson P D; Marsden C D
Hereditary myoclonic dystonia, hereditary torsion dystonia and hereditary essential myoclonus: an area of confusion.
Advances in neurology 1988;50():391-401.
1988: Leenders K L; Quinn N; Frackowiak R S; Marsden C D
Brain dopaminergic system studied in patients with dystonia using positron emission tomography.
Advances in neurology 1988;50():243-7.
1988: Elston J S; Marsden C D; Grandas F; Quinn N P
The significance of ophthalmological symptoms in idiopathic blepharospasm.
Eye (London, England) 1988;2 ( Pt 4)():435-9.
1988: Brown R G; Marsden C D
An investigation of the phenomenon of "set" in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1988;3(2):152-61.
1988: Rose S; Jenner P; Marsden C D
The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats.
Movement disorders : official journal of the Movement Disorder Society 1988;3(2):117-25.
1988: Fletcher N A; Stell R; Harding A E; Marsden C D
Degenerative cerebellar ataxia and focal dystonia.
Movement disorders : official journal of the Movement Disorder Society 1988;3(4):336-42.
1988: Coleman R J; Quinn N P; Marsden C D
Multiple sclerosis presenting as adult onset dystonia.
Movement disorders : official journal of the Movement Disorder Society 1988;3(4):329-32.
1988: Gibb W R; Lees A J; Marsden C D
Pathological report of four patients presenting with cranial dystonias.
Movement disorders : official journal of the Movement Disorder Society 1988;3(3):211-21.
1988: Harrington R C; Wieck A; Marks I M; Marsden C D
Writer's cramp: not associated with anxiety.
Movement disorders : official journal of the Movement Disorder Society 1988;3(3):195-200.
1988: Horowski R; Marsden C D; Obeso J A
Continuous dopaminergic stimulation: state of the art and outlook.
Journal of neural transmission. Supplementum 1988;27():249-52.
1988: Nygaard T G; Marsden C D; Duvoisin R C
Dopa-responsive dystonia.
Advances in neurology 1988;50():377-84.
1988: Marsden C D
Investigation of dystonia.
Advances in neurology 1988;50():35-44.
1988: Critchley P H; Grandas Perez F; Quinn N P; Parkes J D; Marsden C D
Continuous subcutaneous lisuride infusions in Parkinson's disease.
Journal of neural transmission. Supplementum 1988;27():55-60.
1988: Stewart B R; Jenner P; Marsden C D
The pharmacological characterisation of pilocarpine-induced purposeless chewing behaviour in the rat.
Psychopharmacology 1988;96(1):55-62.
1988: Jenner P; Boyce S; Marsden C D
Receptor changes during chronic dopaminergic stimulation.
Journal of neural transmission. Supplementum 1988;27():161-75.
1988: Stewart B R; Rupniak N M; Jenner P; Marsden C D
Animal models of neuroleptic-induced acute dystonia.
Advances in neurology 1988;50():343-59.
1988: Jenner P; Marsden C D
Adaptive changes in brain dopamine function as a result of neuroleptic treatment.
Advances in neurology 1988;49():417-31.
1988: Rothwell J C; Day B L; Obeso J A; Berardelli A; Marsden C D
Reciprocal inhibition between muscles of the human forearm in normal subjects and in patients with idiopathic torsion dystonia.
Advances in neurology 1988;50():133-40.
1987: Van de Waterbeemd H; Testa B; Marrel C; Cooper D R; Jenner P; Marsden C D
Multivariate statistical analysis of L-dopa esters as potential anti-parkinsonian prodrugs.
Drug design and delivery 1987;2(2):135-43.
1987: Marsden C D
Wilson's disease.
The Quarterly journal of medicine 1987;65(248):959-66.
1987: Testa B; Jenner P; Kilpatrick G J; el Tayar N; Van de Waterbeemd H; Marsden C D
Do thermodynamic studies provide information on both the binding to and the activation of dopaminergic and other receptors?
Biochemical pharmacology 1987;36(23):4041-6.
1987: Waters C M; Hunt S P; Jenner P; Marsden C D
An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.
Neuroscience 1987;23(3):1025-39.
1987: Nissenbaum H; Quinn N P; Brown R G; Toone B; Gotham A M; Marsden C D
Mood swings associated with the 'on-off' phenomenon in Parkinson's disease.
Psychological medicine 1987;17(4):899-904.
1987: Dexter D T; Wells F R; Agid F; Agid Y; Lees A J; Jenner P; Marsden C D
Increased nigral iron content in postmortem parkinsonian brain.
Lancet 1987;2(8569):1219-20.
1987: Day B L; Rothwell J C; Thompson P D; Dick J P; Cowan J M; Berardelli A; Marsden C D
Motor cortex stimulation in intact man. 2. Multiple descending volleys.
Brain : a journal of neurology 1987;110 ( Pt 5)():1191-209.
1987: Rothwell J C; Thompson P D; Day B L; Dick J P; Kachi T; Cowan J M; Marsden C D
Motor cortex stimulation in intact man. 1. General characteristics of EMG responses in different muscles.
Brain : a journal of neurology 1987;110 ( Pt 5)():1173-90.
1987: Berardelli A; Day B L; Marsden C D; Rothwell J C
Evidence favouring presynaptic inhibition between antagonist muscle afferents in the human forearm.
The Journal of physiology 1987;391():71-83.
1987: Stewart B; Rose S; Jenner P; Marsden C D
Pilocarpine-induced purposeless chewing behaviour in rats is dependent on intact central stores of 5-HT.
European journal of pharmacology 1987;142(1):173-6.
1987: Cooper D R; Marrel C; van de Waterbeemd H; Testa B; Jenner P; Marsden C D
L-dopa esters as potential prodrugs: effect on brain concentration of dopamine metabolites in reserpinized mice.
The Journal of pharmacy and pharmacology 1987;39(10):809-18.
1987: Jenner P; Marsden C D
Neuroleptic-induced tardive dyskinesia.
Acta psychiatrica Belgica 1987;87(5):566-98.
1987: Testa B; el Tayar N; Carrupt P A; Van de Waterbeemd H; Kilpatrick G J; Jenner P; Marsden C D
The influence of aromatic substituents on the binding of substituted benzamides to dopamine D-2 receptors: congruent QSAR and MEP analyses.
The Journal of pharmacy and pharmacology 1987;39(9):767-8.
1987: Marsden C D; Rothwell J C
The physiology of idiopathic dystonia.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1987;14(3 Suppl):521-7.
1987: Thompson P D; Day B L; Rothwell J C; Dick J P; Cowan J M; Asselman P; Griffin G B; Sheehy M P; Marsden C D
The interpretation of electromyographic responses to electrical stimulation of the motor cortex in diseases of the upper motor neurone.
Journal of the neurological sciences 1987;80(1):91-110.
1987: Hong M; Kilpatrick G J; Jenner P; Marsden C D
Effects of continuous administration for 12 months of amine-depleting drugs and chlorpromazine on striatal dopamine function in the rat.
Neuropharmacology 1987;26(8):1061-9.
1987: Cooper D R; Marrel C; van de Waterbeemd H; Testa B; Jenner P; Marsden C D
L-dopa esters as potential prodrugs: behavioural activity in experimental models of Parkinson's disease.
The Journal of pharmacy and pharmacology 1987;39(8):627-35.
1987: Jenner P; Marsden C D
Chronic pharmacological manipulation of dopamine receptors in brain.
Neuropharmacology 1987;26(7B):931-40.
1987: Waters C M; Hunt S P; Jenner P; Marsden C D
Localization of neurotensin receptors in the forebrain of the common marmoset and the effects of treatment with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Brain research 1987;412(2):244-53.
1987: Dexter D T; Boyce S; Jenner P; Marsden C D
Chronic trifluoperazine treatment does not induce lipid peroxidation in the rat cortex.
Neuroscience letters 1987;76(3):368-71.
1987: Gibb C; Willoughby J; Glover V; Sandler M; Testa B; Jenner P; Marsden C D
Analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as monoamine oxidase substrates: a second ring is not necessary.
Neuroscience letters 1987;76(3):316-22.
1987: Dewar D; Jenner P; Marsden C D
Effects of opioid agonist drugs on the in vitro release of 3H-GABA, 3H-dopamine and 3H-5HT from slices of rat globus pallidus.
Biochemical pharmacology 1987;36(10):1738-41.
1987: Dick J P; Rothwell J C; Day B L; Wise R J; Benecke R; Marsden C D
Modulation of the long-latency reflex to stretch by the supplementary motor area in humans.
Neuroscience letters 1987;75(3):349-54.
1987: Thompson P D; Dick J P; Asselman P; Griffin G B; Day B L; Rothwell J C; Sheehy M P; Marsden C D
Examination of motor function in lesions of the spinal cord by stimulation of the motor cortex.
Annals of neurology 1987;21(4):389-96.
1987: Benecke R; Rothwell J C; Dick J P; Day B L; Marsden C D
Disturbance of sequential movements in patients with Parkinson's disease.
Brain : a journal of neurology 1987;110 ( Pt 2)():361-79.
1987: Weller M E; Rose S; Jenner P; Marsden C D
In vitro characterisation of dopamine receptors in the superior colliculus of the rat.
Neuropharmacology 1987;26(4):347-54.
1987: De Ceballos M L; Boyce S; Taylor M; Jenner P; Marsden C D
Age-related decreases in the concentration of Met- and Leu-enkephalin and neurotensin in the basal ganglia of rats.
Neuroscience letters 1987;75(1):113-7.
1987: Day B L; Thompson P D; Dick J P; Nakashima K; Marsden C D
Different sites of action of electrical and magnetic stimulation of the human brain.
Neuroscience letters 1987;75(1):101-6.
1987: Benecke R; Rothwell J C; Dick J P; Day B L; Marsden C D
Simple and complex movements off and on treatment in patients with Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1987;50(3):296-303.
1987: Kelly E; Jenner P; Marsden C D
Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats.
The Journal of pharmacy and pharmacology 1987;39(3):196-202.
1987: Chivers J; Jenner P; Marsden C D
Pharmacological characterization of binding sites identified in rat brain following in vivo administration of [3H]-spiperone.
British journal of pharmacology 1987;90(3):467-78.
1987: Dick J P; Cantello R; Buruma O; Gioux M; Benecke R; Day B L; Rothwell J C; Thompson P D; Marsden C D
The Bereitschaftspotential, L-DOPA and Parkinson's disease.
Electroencephalography and clinical neurophysiology 1987;66(3):263-74.
1987: Hong M; Jenner P; Marsden C D
Comparison of the acute actions of amine-depleting drugs and dopamine receptor antagonists on dopamine function in the brain in rats.
Neuropharmacology 1987;26(2-3):237-45.
1987: Quinn N P; Rossor M N; Marsden C D
Olfactory threshold in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1987;50(1):88-9.
1987: Marsden C D
Parkinson's disease in twins.
Journal of neurology, neurosurgery, and psychiatry 1987;50(1):105-6.
1987: Rothwell J C; Day B L; Thompson P D; Dick J P; Marsden C D
Some experiences of techniques for stimulation of the human cerebral motor cortex through the scalp.
Neurosurgery 1987;20(1):156-63.
1987: Rupniak N M; Prestwich S A; Horton R W; Jenner P; Marsden C D
Alterations in cerebral glutamic acid decarboxylase and 3H-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapine.
Journal of neural transmission 1987;68(1-2):113-25.
1987: Marsden C D; Jenner P G
The significance of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Ciba Foundation symposium 1987;126():239-56.
1987: Marion M H; Stocchi F; Quinn N P; Jenner P; Marsden C D
Single-dose study of slow release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease.
Advances in neurology 1987;45():493-6.
1987: Quinn N; Critchley P; Marsden C D
Young onset Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1987;2(2):73-91.
1987: Nomoto M; Thompson P D; Sheehy M P; Quinn N P; Marsden C D
Anticholinergic-induced chorea in the treatment of focal dystonia.
Movement disorders : official journal of the Movement Disorder Society 1987;2(1):53-6.
1987: Thompson P D; Marsden C D
Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger's disease.
Movement disorders : official journal of the Movement Disorder Society 1987;2(1):1-8.
1987: Malcolm S L; Allen J G; Bird H; Quinn N P; Marion M H; Marsden C D; O'Leary C G
Single-dose pharmacokinetics of Madopar HBS in patients and effect of food and antacid on the absorption of Madopar HBS in volunteers.
European neurology 1987;27 Suppl 1():28-35.
1987: Marion M H; Stocchi F; Malcolm S L; Quinn N P; Jenner P; Marsden C D
Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease.
European neurology 1987;27 Suppl 1():54-8.
1987: Quinn N P; Marion M H; Marsden C D
Open study of Madopar HBS, a new formulation of levodopa with benserazide, in 13 patients with Parkinson's disease and 'on-off' fluctuations.
European neurology 1987;27 Suppl 1():105-13.
1987: Gibb W R; Lees A J; Wells F R; Barnard R O; Jenner P; Marsden C D
Pathology of MPTP in the marmoset.
Advances in neurology 1987;45():187-90.
1987: Marsden C D
What do the basal ganglia tell premotor cortical areas?
Ciba Foundation symposium 1987;132():282-300.
1987: Grandas F; Quinn N; Critchley P; Rohan A; Marsden C D; Stahl S M
Antiparkinsonian activity of a single oral dose of PHNO.
Movement disorders : official journal of the Movement Disorder Society 1987;2(1):47-51.
1987: Nomoto M; Stahl S; Jenner P; Marsden C D
Antiparkinsonian activity of (+)-PHNO in the MPTP-treated common marmoset.
Movement disorders : official journal of the Movement Disorder Society 1987;2(1):37-45.
1987: Moser A; Reavill C; Liebetrau A; Jenner P; Marsden C D; Cramer H
Dopamine and somatostatin modulated adenylate cyclase activity in the rat caudate-putamen following unilateral cortical ablation.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1987;68(2):406-10.
1987: Jenner P; Rose S; Nomoto M; Marsden C D
MPTP-induced parkinsonism in the common marmoset: behavioral and biochemical effects.
Advances in neurology 1987;45():183-6.
1986: Dick J P; Rothwell J C; Berardelli A; Thompson P D; Gioux M; Benecke R; Day B L; Marsden C D
Associated postural adjustments in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1986;49(12):1378-85.
1986: Kilpatrick G J; Jenner P; Marsden C D
[3H]SCH 23390 identifies D-1 binding sites in rat striatum and other brain areas.
The Journal of pharmacy and pharmacology 1986;38(12):907-12.
1986: Berardelli A; Dick J P; Rothwell J C; Day B L; Marsden C D
Scaling of the size of the first agonist EMG burst during rapid wrist movements in patients with Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1986;49(11):1273-9.
1986: De Ceballos M L; Boyce S; Jenner P; Marsden C D
Alterations in [Met5]- and [Leu5]enkephalin and neurotensin content in basal ganglia induced by the long-term administration of dopamine agonist and antagonist drugs to rats.
European journal of pharmacology 1986;130(3):305-9.
1986: Jenner P; Taquet H; Mauborgne A; Benoliel J T; Cesselin F; Rose S; Javoy-Agid F; Agid Y; Marsden C D
Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmoset.
Journal of neurochemistry 1986;47(5):1548-51.
1986: Brown R G; Marsden C D
Visuospatial function in Parkinson's disease.
Brain : a journal of neurology 1986;109 ( Pt 5)():987-1002.
1986: Simpson M D; Jenner P; Marsden C D
Hypophysectomy may non-selectively alter pharmacokinetic parameters to enhance the ability of haloperidol to increase striatal dopamine receptor density in the rat.
Biochemical pharmacology 1986;35(20):3501-6.
1986: Simpson M D; Jenner P; Marsden C D
Hyperprolactinaemia does not alter specific striatal 3H-spiperone binding in the rat.
Biochemical pharmacology 1986;35(19):3203-8.
1986: Quinn N; Critchley P; Parkes D; Marsden C D
When should levodopa be started?
Lancet 1986;2(8513):985-6.
1986: Gotham A M; Brown R G; Marsden C D
Levodopa treatment may benefit or impair "frontal" function in Parkinson's disease.
Lancet 1986;2(8513):970-1.
1986: Kilpatrick G J; el Tayar N; Van de Waterbeemd H; Jenner P; Testa B; Marsden C D
The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors.
Molecular pharmacology 1986;30(3):226-34.
1986: Dexter D; Carter C; Agid F; Agid Y; Lees A J; Jenner P; Marsden C D
Lipid peroxidation as cause of nigral cell death in Parkinson's disease.
Lancet 1986;2(8507):639-40.
1986: Repond C; Pratt J A; Stolerman I P; Mayer J M; Jenner P; Marsden C D; Testa B
Affinity of pyridylalkylamines for nicotinic, muscarinic and histaminic recognition sites in brain tissue preparations.
Arzneimittel-Forschung 1986;36(8):1191-4.
1986: Bradbury A J; Costall B; Jenner P G; Kelly M E; Marsden C D; Naylor R J
MPP+ can disrupt the nigrostriatal dopamine system by acting in the terminal area.
Neuropharmacology 1986;25(8):939-41.
1986: De Ceballos M L; Jenner P; Marsden C D
Acute and repeated administration of sulpiride alters Met-and Leu-enkephalin content of rat brain.
Neuroscience letters 1986;68(3):322-6.
1986: Benecke R; Rothwell J C; Dick J P; Day B L; Marsden C D
Performance of simultaneous movements in patients with Parkinson's disease.
Brain : a journal of neurology 1986;109 ( Pt 4)():739-57.
1986: Leenders K L; Palmer A J; Quinn N; Clark J C; Firnau G; Garnett E S; Nahmias C; Jones T; Marsden C D
Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.
Journal of neurology, neurosurgery, and psychiatry 1986;49(8):853-60.
1986: Bradbury A J; Costall B; Jenner P G; Kelly M E; Marsden C D; Naylor R J
The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal and limbic catecholamine neurones in white and black mice. Antagonism by monoamine oxidase inhibitors.
Neuropharmacology 1986;25(8):897-904.
1986: Critchley P; Grandas Perez F; Quinn N; Coleman R; Parkes D; Marsden C D
Psychosis and the lisuride pump.
Lancet 1986;2(8502):349.
1986: Cowan J M; Rothwell J C; Wise R J; Marsden C D
Electrophysiological and positron emission studies in a patient with cortical myoclonus, epilepsia partialis continua and motor epilepsy.
Journal of neurology, neurosurgery, and psychiatry 1986;49(7):796-807.
1986: Thompson P D; Obeso J A; Delgado G; Gallego J; Marsden C D
Focal dystonia of the jaw and the differential diagnosis of unilateral jaw and masticatory spasm.
Journal of neurology, neurosurgery, and psychiatry 1986;49(6):651-6.
1986: Thompson P D; Rothwell J C; Day B L; Berardelli A; Dick J P; Kachi T; Marsden C D
The physiology of orthostatic tremor.
Archives of neurology 1986;43(6):584-7.
1986: Quinn N; Marsden C D
Lithium for painful dystonia in Parkinson's disease.
Lancet 1986;1(8494):1377.
1986: Quinn N P; Koller W C; Lang A E; Marsden C D
Painful Parkinson's disease.
Lancet 1986;1(8494):1366-9.
1986: Bradbury A J; Costall B; Domeney A M; Jenner P J; Marsden C D; Naylor R J
The neurotoxic actions of 6-hydroxydopamine infused into the rat substantia nigra.
Neuroscience letters 1986;67(2):208-12.
1986: Marsden C D
Hysteria--a neurologist's view.
Psychological medicine 1986;16(2):277-88.
1986: Marsden C D; Lang A E; Quinn N P; McDonald W I; Abdallat A; Nimri S
Familial dystonia and visual failure with striatal CT lucencies.
Journal of neurology, neurosurgery, and psychiatry 1986;49(5):500-9.
1986: Kilpatrick G J; Jenner P; Marsden C D
[125I]Spiperone is not a useful ligand for studying the CHAPS solubilized dopamine D-2 receptor from rat striatum.
The Journal of pharmacy and pharmacology 1986;38(5):406-8.
1986: Gotham A M; Brown R G; Marsden C D
Depression in Parkinson's disease: a quantitative and qualitative analysis.
Journal of neurology, neurosurgery, and psychiatry 1986;49(4):381-9.
1986: Grandas Perez F J; Jenner P G; Nomoto M; Stahl S; Quinn N P; Parkes J D; Critchley P; Marsden C D
(+)-4-Propyl-9-hydroxynaphthoxazine in Parkinson's disease.
Lancet 1986;1(8486):906.
1986: Boyd S G; Rothwell J C; Cowan J M; Webb P J; Morley T; Asselman P; Marsden C D
A method of monitoring function in corticospinal pathways during scoliosis surgery with a note on motor conduction velocities.
Journal of neurology, neurosurgery, and psychiatry 1986;49(3):251-7.
1986: Gibb W R; Lees A J; Jenner P; Marsden C D
The dopamine neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces histological lesions in the hypothalamus of the common marmoset.
Neuroscience letters 1986;65(1):79-83.
1986: Quinn N P; Marsden C D
Coincidence of Wilson's disease with other movement disorders in the same family.
Journal of neurology, neurosurgery, and psychiatry 1986;49(2):221-2.
1986: Kilpatrick G J; Jenner P; Marsden C D
Specific [3H]piflutixol binding to CHAPS-solubilised rat striatal preparations involves dopamine D-2 but not D-1 binding sites.
Journal of neurochemistry 1986;46(2):413-21.
1986: Burke R E; Fahn S; Marsden C D
Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl.
Neurology 1986;36(2):160-4.
1986: Nomoto M; Jenner P; Marsden C D
Alterations in motor behaviour produced by the isomers of 3-PPP in the MPTP-treated marmoset.
European journal of pharmacology 1986;121(1):123-8.
1986: Davis A S; Jenner P; Marsden C D
A comparison of motor behaviours in groups of rats distinguished by their climbing response to apomorphine.
British journal of pharmacology 1986;87(1):129-37.
1986: Berardelli A; Thompson P D; Day B L; Rothwell J C; O'Brien M D; Marsden C D
Dystonia of the legs induced by walking or passive movement of the big toe in a patient with cerebellar ectopia and syringomyelia.
Neurology 1986;36(1):40-4.
1986: Bradbury A J; Costall B; Domeney A M; Jenner P; Kelly M E; Marsden C D; Naylor R J
1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
Nature 1986;319(6048):56-7.
1986: Quinn N P; Rossor M N; Marsden C D
Dementia and Parkinson's disease--pathological and neurochemical considerations.
British medical bulletin 1986;42(1):86-90.
1986: Muscatt S; Rothwell J; Obeso J; Leigh N; Jenner P; Marsden C D
Urea-induced stimulus-sensitive myoclonus in the rat.
Advances in neurology 1986;43():553-63.
1986: Obeso J A; Viteri C; Martínez Lage J M; Marsden C D
Toxic myoclonus.
Advances in neurology 1986;43():225-30.
1986: Obeso J A; Rothwell J C; Quinn N P; Lang A E; Artieda J; Marsden C D
Lisuride in the treatment of myoclonus.
Advances in neurology 1986;43():191-6.
1986: Fahn S; Marsden C D; Van Woert M H
Definition and classification of myoclonus.
Advances in neurology 1986;43():1-5.
1986: Marsden C D
Clinical relevance of neuropeptide research.
Progress in brain research 1986;66():369-74.
1986: Benecke R; Rothwell J C; Day B L; Dick J P; Marsden C D
Motor strategies involved in the performance of sequential movements.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1986;63(3):585-95.
1986: Rothwell J C; Day B L; Berardelli A; Marsden C D
Habituation and conditioning of the human long latency stretch reflex.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1986;63(1):197-204.
1986: Rupniak N M; Briggs R S; Petersen M M; Mann S; Reavill C; Jenner P; Marsden C D
Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine.
Clinical neuropharmacology 1986;9(3):282-92.
1986: Marion M H; Stocchi F; Quinn N P; Jenner P; Marsden C D
Repeated levodopa infusions in fluctuating Parkinson's disease: clinical and pharmacokinetic data.
Clinical neuropharmacology 1986;9(2):165-81.
1986: Rothwell J C; Obeso J A; Marsden C D
Electrophysiology of somatosensory reflex myoclonus.
Advances in neurology 1986;43():385-98.
1986: Obeso J A; Rothwell J C; Marsden C D
Somatosensory evoked potentials in myoclonus.
Advances in neurology 1986;43():373-84.
1986: Dick J P; Benecke R; Rothwell J C; Day B L; Marsden C D
Simple and complex movements in a patient with infarction of the right supplementary motor area.
Movement disorders : official journal of the Movement Disorder Society 1986;1(4):255-66.
1986: de Ceballos M L; Baker M; Rose S; Jenner P; Marsden C D
Do enkephalins in basal ganglia mediate a physiological motor rest mechanism?
Movement disorders : official journal of the Movement Disorder Society 1986;1(4):223-33.
1986: Lu C S; Thompson P D; Quinn N P; Parkes J D; Marsden C D
Ramsay Hunt syndrome and coeliac disease: a new association?
Movement disorders : official journal of the Movement Disorder Society 1986;1(3):209-19.
1986: Fahn S; Marsden C D
The video medium creates new responsibilities and opportunities.
Movement disorders : official journal of the Movement Disorder Society 1986;1(2):91-2.
1986: Thompson P D; Dick J P; Day B L; Rothwell J C; Berardelli A; Kachi T; Marsden C D
Electrophysiology of the corticomotoneurone pathways in patients with movement disorders.
Movement disorders : official journal of the Movement Disorder Society 1986;1(2):113-7.
1986: Quinn N P; Marsden C D
Menstrual-related fluctuations in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1986;1(1):85-7.
1986: Quinn N; Parkes D; Janota I; Marsden C D
Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year period.
Movement disorders : official journal of the Movement Disorder Society 1986;1(1):65-8.
1986: Marsden C D
The focal dystonias.
Clinical neuropharmacology 1986;9 Suppl 2():S49-60.
1986: Garvey J; Petersen M; Waters C M; Rose S P; Hunt S; Briggs R; Jenner P; Marsden C D
Administration of MPTP to the common marmoset does not alter cortical cholinergic function.
Movement disorders : official journal of the Movement Disorder Society 1986;1(2):129-34.
1986: Jenner P; Marsden C D
The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Journal of neural transmission. Supplementum 1986;20():11-39.
1986: Marsden C D; Sandler M
The MPTP story: an introduction.
Journal of neural transmission. Supplementum 1986;20():1-3.
1986: Leenders K L; Frackowiak R S; Quinn N; Marsden C D
Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography.
Movement disorders : official journal of the Movement Disorder Society 1986;1(1):69-77.
1986: Leenders K L; Frackowiak R S; Quinn N; Brooks D; Sumner D; Marsden C D
Ipsilateral blepharospasm and contralateral hemidystonia and parkinsonism in a patient with a unilateral rostral brainstem-thalamic lesion: structural and functional abnormalities studied with CT, MRI, and PET scanning.
Movement disorders : official journal of the Movement Disorder Society 1986;1(1):51-8.
1986: Moser A; Reavill C; Jenner P; Marsden C D; Cramer H
Effects of somatostatin on dopamine sensitive adenylate cyclase activity in the caudate-putamen of the rat.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1986;62(3):567-71.
1986: Rupniak N M; Jenner P; Marsden C D
Acute dystonia induced by neuroleptic drugs.
Psychopharmacology 1986;88(4):403-19.
1986: Jenner P; Pratt J A; Marsden C D
Mechanism of action of clonazepam in myoclonus in relation to effects on GABA and 5-HT.
Advances in neurology 1986;43():629-43.
1986: Pratt J A; Rothwell J; Jenner P; Marsden C D
p,p'-DDT-induced myoclonus in the rat and its application as an animal model of 5-HT-sensitive action myoclonus.
Advances in neurology 1986;43():577-88.
1986: Luscombe G; Jenner P; Marsden C D
5-HT-mediated myoclonus in the guinea pig as a model of brainstem 5-HT and tryptamine receptor action.
Advances in neurology 1986;43():529-43.
1986: Chadwick D; Hallett M; Jenner P; Marsden C D
Treatment of posthypoxic action myoclonus: implications for the pathophysiology of the disorder.
Advances in neurology 1986;43():183-90.
1985: Benecke R; Dick J P; Rothwell J C; Day B L; Marsden C D
Increase of the Bereitschaftspotential in simultaneous and sequential movements.
Neuroscience letters 1985;62(3):347-52.
1985: Fitzmaurice H; Fowler C J; Rickards D; Kirby R S; Quinn N P; Marsden C D; Milroy E J; Turner-Warwick R T
Micturition disturbance in Parkinson's disease.
British journal of urology 1985;57(6):652-6.
1985: Quinn N; Bydder G; Leenders N; Marsden C D
Magnetic resonance imaging to detect deep basal ganglia lesions in hemidystonia that are missed by computerised tomography.
Lancet 1985;2(8462):1007-8.
1985: Bradbury A J; Costall B; Domeney A M; Testa B; Jenner P G; Marsden C D; Naylor R J
The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
Neuroscience letters 1985;61(1-2):121-6.
1985: Berardelli A; Rothwell J C; Day B L; Marsden C D
Pathophysiology of blepharospasm and oromandibular dystonia.
Brain : a journal of neurology 1985;108 ( Pt 3)():593-608.
1985: Obeso J A; Artieda J; Marsden C D
Stretch reflex blepharospasm.
Neurology 1985;35(9):1378-80.
1985: Testa B; Naylor R; Costall B; Jenner P; Marsden C D
Does an endogenous methylpyridinium analogue cause Parkinson's disease?
The Journal of pharmacy and pharmacology 1985;37(9):679-80.
1985: Kahn J; Anderton B H; Gibb W R; Lees A J; Wells F R; Marsden C D
Neuronal filaments in Alzheimer's, Pick's, and Parkinson's diseases.
The New England journal of medicine 1985;313(8):520-1.
1985: Rupniak N M; Hall M D; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden C D
Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
Biochemical pharmacology 1985;34(15):2755-63.
1985: Kelly E; Jenner P; Marsden C D
The effects of dopamine and dopamine agonists on the release of 3H-GABA and 3H-5HT from rat nigral slices.
Biochemical pharmacology 1985;34(15):2655-62.
1985: Fine A; Reynolds G P; Nakajima N; Jenner P; Marsden C D
Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine affects the adrenal glands as well as the brain in the marmoset.
Neuroscience letters 1985;58(1):123-6.
1985: Kelly E; Jenner P; Marsden C D
Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
Journal of neurochemistry 1985;45(1):137-44.
1985: Bradbury A J; Costall B; Jenner P G; Kelly M E; Marsden C D; Naylor R J
The neurotoxic actions of 1-methyl-4-phenylpyridine (MPP+) are not prevented by deprenyl treatment.
Neuroscience letters 1985;58(2):177-81.
1985: Kachi T; Rothwell J C; Cowan J M; Marsden C D
Writing tremor: its relationship to benign essential tremor.
Journal of neurology, neurosurgery, and psychiatry 1985;48(6):545-50.
1985: Marsden C D; Obeso J A; Zarranz J J; Lang A E
The anatomical basis of symptomatic hemidystonia.
Brain : a journal of neurology 1985;108 ( Pt 2)():463-83.
1985: Berardelli A; Cruccu G; Manfredi M; Rothwell J C; Day B L; Marsden C D
The corneal reflex and the R2 component of the blink reflex.
Neurology 1985;35(6):797-801.
1985: Nomoto M; Jenner P; Marsden C D
The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset.
Neuroscience letters 1985;57(1):37-41.
1985: Pratt J A; Rothwell J; Jenner P; Marsden C D
Myoclonus in the rat induced by p,p'-DDT and the role of altered monoamine function.
Neuropharmacology 1985;24(5):361-73.
1985: Kelly E; Jenner P; Marsden C D
Lack of effect of intranigral administration of a dopamine analogue, (+/-)-3-(3-hydroxyphenyl)-N,n-propylpiperidine [(+/-)-3-PPP], on nigrostriatal dopamine neurones.
Neuroscience letters 1985;56(1):57-62.
1985: Quinn N P; Lang A E; Sheehy M P; Marsden C D
Lisuride in dystonia.
Neurology 1985;35(5):766-9.
1985: Dewar D; Jenner P; Marsden C D
Behavioural effects in rats of unilateral and bilateral injections of opiate receptor agonists into the globus pallidus.
Neuroscience 1985;15(1):41-6.
1985: Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden C D
SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
Biochemical pharmacology 1985;34(10):1665-9.
1985: Kilpatrick G J; Jenner P; Marsden C D
Properties of rat striatal D-2 dopamine receptors solubilized with the zwitterionic detergent CHAPS.
The Journal of pharmacy and pharmacology 1985;37(5):320-8.
1985: Obeso J A; Rothwell J C; Marsden C D
The spectrum of cortical myoclonus. From focal reflex jerks to spontaneous motor epilepsy.
Brain : a journal of neurology 1985;108 ( Pt 1)():193-24.
1985: Critchley P; Langdon N; Parkes J D; Quinn N P; Shindler J S; Marsden C D
Domperidone.
British medical journal (Clinical research ed.) 1985;290(6470):788.
1985: Quinn N; Marsden C D
Tiapride in 12 Huntington's disease patients.
Journal of neurology, neurosurgery, and psychiatry 1985;48(3):292.
1985: Burke R E; Fahn S; Marsden C D; Bressman S B; Moskowitz C; Friedman J
Validity and reliability of a rating scale for the primary torsion dystonias.
Neurology 1985;35(1):73-7.
1985: Pratt J A; Jenner P; Marsden C D
Comparison of the effects of benzodiazepines and other anticonvulsant drugs on synthesis and utilization of 5-HT in mouse brain.
Neuropharmacology 1985;24(1):59-68.
1985: Abbruzzese G; Berardelli A; Rothwell J C; Day B L; Marsden C D
Cerebral potentials and electromyographic responses evoked by stretch of wrist muscles in man.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1985;58(3):544-51.
1985: Murugaiah K; Theodorou A; Clow A; Jenner P; Marsden C D
Effects of discontinuous drug administration on the development of dopamine receptor supersensitivity during chronic trifluoperazine or cis-flupenthixol administration to rats.
Psychopharmacology 1985;86(1-2):228-32.
1985: Jenner P; Rupniak N M; Marsden C D
Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
Psychopharmacology. Supplementum 1985;2():174-81.
1985: Rupniak N M; Hall M D; Kelly E; Fleminger S; Kilpatrick G; Jenner P; Marsden C D
Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs.
Journal of neural transmission 1985;62(3-4):249-66.
1985: Marsden C D
Is tardive dyskinesia a unique disorder?
Psychopharmacology. Supplementum 1985;2():64-71.
1985: Rupniak N M; Jenner P; Marsden C D
Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats.
Psychopharmacology 1985;85(1):71-9.
1984: Day B L; Dick J P; Marsden C D
Patients with Parkinson's disease can employ a predictive motor strategy.
Journal of neurology, neurosurgery, and psychiatry 1984;47(12):1299-306.
1984: Brown R G; Marsden C D
How common is dementia in Parkinson's disease?
Lancet 1984;2(8414):1262-5.
1984: Kilpatrick G J; Jenner P; Marsden C D
The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes.
European journal of pharmacology 1984;107(1):71-8.
1984: Marsden C D; Marion M H; Quinn N
The treatment of severe dystonia in children and adults.
Journal of neurology, neurosurgery, and psychiatry 1984;47(11):1166-73.
1984: Rupniak N M; Jenner P; Marsden C D
Enhancement of stereotypy induced by nomifensine in rats during continuous chronic haloperidol treatment.
Neuroscience letters 1984;50(1-3):63-5.
1984: Quinn N; Parkes J D; Marsden C D
Control of on/off phenomenon by continuous intravenous infusion of levodopa.
Neurology 1984;34(9):1131-6.
1984: Luscombe G; Jenner P; Marsden C D
Correlation of [3H]5-hydroxytryptamine (5HT) binding to brain stem preparations and the production and prevention of myoclonus in guinea pig by 5HT agonists and antagonists.
European journal of pharmacology 1984;104(3-4):235-44.
1984: Jenner P; Rupniak N M; Rose S; Kelly E; Kilpatrick G; Lees A; Marsden C D
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.
Neuroscience letters 1984;50(1-3):85-90.
1984: Dick J P; Cowan J M; Day B L; Berardelli A; Kachi T; Rothwell J C; Marsden C D
The corticomotoneurone connection is normal in Parkinson's disease.
Nature 1984;310(5976):407-9.
1984: Marsden C D
The pathophysiology of movement disorders.
Neurologic clinics 1984;2(3):435-59.
1984: Quinn N; Marsden C D
A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
Journal of neurology, neurosurgery, and psychiatry 1984;47(8):844-7.
1984: Rupniak N M; Boyce S; Jenner P; Marsden C D
Interpretation of changes in apomorphine-induced stereotyped behaviour in rats receiving continuous administration of trifluorperazine for 15 months.
Neuropharmacology 1984;23(8):893-8.
1984: Cowan J M; Rothwell J C; Dick J P; Thompson P D; Day B L; Marsden C D
Abnormalities in central motor pathway conduction in multiple sclerosis.
Lancet 1984;2(8398):304-7.
1984: Narbona J; Obeso J A; Tuñon T; Martinez-Lage J M; Marsden C D
Hemi-dystonia secondary to localised basal ganglia tumour.
Journal of neurology, neurosurgery, and psychiatry 1984;47(7):704-9.
1984: Chivers J K; Hall M D; Kelly E; Jenner P; Marsden C D
Dopamine receptor binding sites in the rat superior colliculus.
The Journal of pharmacy and pharmacology 1984;36(7):484-8.
1984: Berardelli A; Rothwell J C; Day B L; Kachi T; Marsden C D
Duration of the first agonist EMG burst in ballistic arm movements.
Brain research 1984;304(1):183-7.
1984: Boyce S; Kelly E; Reavill C; Jenner P; Marsden C D
Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones.
Biochemical pharmacology 1984;33(11):1747-52.
1984: Murugaiah K; Fleminger S; Hall M D; Theodorou A; Jenner P; Marsden C D
Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats.
Neuropharmacology 1984;23(6):599-609.
1984: Berardelli A; Rothwell J C; Day B L; Marsden C D
Movements not involved in posture are abnormal in Parkinson's disease.
Neuroscience letters 1984;47(1):47-50.
1984: Dick J P; Guiloff R J; Stewart A; Blackstock J; Bielawska C; Paul E A; Marsden C D
Mini-mental state examination in neurological patients.
Journal of neurology, neurosurgery, and psychiatry 1984;47(5):496-9.
1984: Brown R G; Marsden C D; Quinn N; Wyke M A
Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1984;47(5):454-65.
1984: Hall M D; Cooper D R; Fleminger S; Rupniak N M; Jenner P; Marsden C D
Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
Neuropharmacology 1984;23(5):545-53.
1984: Obeso J A; Rothwell J C; Marsden C D
[Hung-up reflexes in Huntington disease. Study of a minor sign]
Archivos de neurobiologiá 1984;47(3):151-6.
1984: Day B L; Marsden C D; Obeso J A; Rothwell J C
Reciprocal inhibition between the muscles of the human forearm.
The Journal of physiology 1984;349():519-34.
1984: Kerwin R; Rupniak N M; Jenner P; Marsden C D
Functional increase in striatal dopaminergic activity following continuous long-term treatment with trifluoperazine.
Neuroscience letters 1984;45(3):329-34.
1984: Plant G T; Williams A C; Earl C J; Marsden C D
Familial paroxysmal dystonia induced by exercise.
Journal of neurology, neurosurgery, and psychiatry 1984;47(3):275-9.
1984: Robinson R O; Stutchfield P; Hicks B; Marsden C D
Estrogens and dyskinesia.
Neurology 1984;34(3):404-5.
1984: Luscombe G; Jenner P; Marsden C D
5-Hydroxytryptamine (5-HT)-dependent myoclonus in guinea pigs is induced through brainstem 5-HT-1 receptors.
Neuroscience letters 1984;44(3):241-6.
1984: Marsden C D
Function of the basal ganglia as revealed by cognitive and motor disorders in Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1984;11(1 Suppl):129-35.
1984: Rothwell J C; Obeso J A; Marsden C D
On the significance of giant somatosensory evoked potentials in cortical myoclonus.
Journal of neurology, neurosurgery, and psychiatry 1984;47(1):33-42.
1984: Marsden C D; Obeso J A; Traub M M; Rothwell J C; Kranz H; La Cruz F
Muscle spasms associated with Sudeck's atrophy after injury.
British medical journal (Clinical research ed.) 1984;288(6412):173-6.
1984: Kerwin R W; Rupniak N M; Jenner P; Marsden C D
A comparison of the effects of acute and one year's continuous neuroleptic treatment on the release of [3H]glutamate and [3H]acetylcholine from rat striatal slices.
Neuroscience 1984;11(1):205-10.
1984: Rothwell J C; Day B L; Berardelli A; Marsden C D
Effects of motor cortex stimulation on spinal interneurones in intact man.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1984;54(2):382-4.
1984: Marsden C D
Motor disorders in basal ganglia disease.
Human neurobiology 1984;2(4):245-50.
1984: Cooper D R; Marrel C; Testa B; van de Waterbeemd H; Quinn N; Jenner P; Marsden C D
L-Dopa methyl ester--a candidate for chronic systemic delivery of L-Dopa in Parkinson's disease.
Clinical neuropharmacology 1984;7(1):89-98.
1984: Quinn N P; Lang A E; Thompson C; Brincat S; Marsden C D; Parkes J D
Pergolide in the treatment of Parkinson's disease.
Advances in neurology 1984;40():509-13.
1984: Kelly E; Jenner P; Marsden C D
Behavioural effects mediated by unilateral nigral dopamine receptor stimulation in the rat.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1984;55(2):243-52.
1984: Marsden C D
Which motor disorder in Parkinson's disease indicates the true motor function of the basal ganglia?
Ciba Foundation symposium 1984;107():225-41.
1984: Reavill C; Muscatt S; Leigh P N; Jenner P; Marsden C D
Enhanced GABA function in the angular complex (lateral periaqueductal grey matter and adjacent reticular formation) alters the postural component of striatal- or nigral-derived circling.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1984;56(1):1-11.
1984: Rupniak N M; Kilpatrick G; Hall M D; Jenner P; Marsden C D
Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
Psychopharmacology 1984;84(4):512-9.
1984: Rupniak N M; Mann S; Hall M D; Fleminger S; Kilpatrick G; Jenner P; Marsden C D
Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat.
Psychopharmacology 1984;84(4):503-11.
1984: Thompson C; Lang A; Parkes J D; Marsden C D
A double-blind trial of clonazepam in benign essential tremor.
Clinical neuropharmacology 1984;7(1):83-8.
1984: Jenner P; Marsden C D
Multiple dopamine receptors in brain and the pharmacological action of substituted benzamide drugs.
Acta psychiatrica Scandinavica. Supplementum 1984;311():109-23.
1984: Reavill C; Jenner P; Marsden C D
Gamma-aminobutyric acid and basal ganglia outflow pathways.
Ciba Foundation symposium 1984;107():164-76.
1983: Murugaiah K; Theodorou A; Jenner P; Marsden C D
Alterations in cerebral dopamine function caused by administration of cis- or trans-flupenthixol for up to 18 months.
Neuroscience 1983;10(3):811-9.
1983: Hall M D; Jenner P; Marsden C D
Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
Biochemical pharmacology 1983;32(19):2973-7.
1983: Fleminger S; Rupniak N M; Hall M D; Jenner P; Marsden C D
Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
Biochemical pharmacology 1983;32(19):2921-7.
1983: Murugaiah K; Fleminger S; Theodorou A; Jenner P; Marsden C D
Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake.
Biochemical pharmacology 1983;32(17):2495-9.
1983: Rupniak N; Hong M; Mansfield S; Fleminger S; Dyer R; Jenner P; Marsden C D
Elevation of circulating prolactin concentrations may not cause striatal dopamine receptor supersensitivity.
European journal of pharmacology 1983;93(3-4):195-200.
1983: Marsden C D; Lang A E; Sheehy M P
Pharmacology of cranial dystonia.
Neurology 1983;33(8):1100-2.
1983: Leigh P N; Jefferson D; Twomey A; Marsden C D
Beta-adrenoreceptor mechanisms in essential tremor; a double-blind placebo controlled trial of metoprolol, sotalol and atenolol.
Journal of neurology, neurosurgery, and psychiatry 1983;46(8):710-5.
1983: Obeso J A; Rothwell J C; Lang A E; Marsden C D
Myoclonic dystonia.
Neurology 1983;33(7):825-30.
1983: Day B L; Rothwell J C; Marsden C D
Interaction between the long-latency stretch reflex and voluntary electromyographic activity prior to a rapid voluntary motor reaction.
Brain research 1983;270(1):55-62.
1983: Hall M D; Jenner P; Kelly E; Marsden C D
Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
British journal of pharmacology 1983;79(2):599-610.
1983: Day B L; Rothwell J C; Marsden C D
Transmission in the spinal reciprocal Ia inhibitory pathway preceding willed movements of the human wrist.
Neuroscience letters 1983;37(3):245-50.
1983: Luscombe G; Jenner P; Marsden C D
Alterations in brain 5HT and tryptamine content during indoleamine-induced myoclonus in guinea pigs.
Biochemical pharmacology 1983;32(12):1857-64.
1983: Fleminger S; van de Waterbeemd H; Rupniak N M; Reavill C; Testa B; Jenner P; Marsden C D
Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the rat.
The Journal of pharmacy and pharmacology 1983;35(6):363-8.
1983: Reynolds G P; Garrett N J; Rupniak N; Jenner P; Marsden C D
Chronic clozapine treatment of rats down-regulates cortical 5-HT2 receptors.
European journal of pharmacology 1983;89(3-4):325-6.
1983: Rupniak M N; Jenner P; Marsden C D
The effect of chronic neuroleptic administration on cerebral dopamine receptor function.
Life sciences 1983;32(20):2289-311.
1983: Quinn N P; Toone B; Lang A E; Marsden C D; Parkes J D
Dopa dose-dependent sexual deviation.
The British journal of psychiatry : the journal of mental science 1983;142():296-8.
1983: Theodorou A E; Jenner P; Marsden C D
Cation specificity of 3H-sulpiride binding involves alteration in the number of striatal binding sites.
Life sciences 1983;32(11):1243-54.
1983: Marsden C D
Writer's cramp.
British medical journal (Clinical research ed.) 1983;286(6370):1057.
1983: Reavill C; Jenner P; Marsden C D
Differentiation of dopamine agonists using drug-induced rotation in rats with unilateral or bilateral 6-hydroxydopamine destruction of ascending dopamine pathways.
Biochemical pharmacology 1983;32(5):865-70.
1983: Reynolds L M; Dyer R G; Jenner P; Marsden C D
Hypophysectomy does not prevent increased cerebral dopamine turnover following sulpiride administration.
The Journal of pharmacy and pharmacology 1983;35(3):170-4.
1983: Marsden C D; Obeso J A; Rothwell J C
The function of the antagonist muscle during fast limb movements in man.
The Journal of physiology 1983;335():1-13.
1983: Obeso J A; Lang A E; Rothwell J C; Marsden C D
Postanoxic symptomatic oscillatory myoclonus.
Neurology 1983;33(2):240-3.
1983: Rothwell J C; Obeso J A; Traub M M; Marsden C D
The behaviour of the long-latency stretch reflex in patients with Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1983;46(1):35-44.
1983: Lang A E; Marsden C D
Spasmodic dysphonia in Gilles de la Tourette's disease.
Archives of neurology 1983;40(1):51-2.
1983: Hall M D; Jenner P; Marsden C D
Differential labelling of dopamine receptors in rat brain in vivo: comparison of [3H]piribedil, [3H]S 3608 and [3H]N,n-propylnorapomorphine.
European journal of pharmacology 1983;87(1):85-94.
1983: Lang A E; Sheehy M P; Quinn N P; Brincat S; Marsden C D; Parkes D
Lisuride and pergolide in Parkinson's disease.
Advances in neurology 1983;37():109-20.
1983: Rothwell J C; Obeso J A; Day B L; Marsden C D
Pathophysiology of dystonias.
Advances in neurology 1983;39():851-63.
1983: Marsden C D; Merton P A; Morton H B
Rapid postural reactions to mechanical displacement of the hand in man.
Advances in neurology 1983;39():645-59.
1983: Dewar D; Jenner P; Marsden C D
Lesions of the globus pallidus, entopeduncular nucleus and substantia nigra alter dopamine mediated circling behaviour.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1983;52(2):281-92.
1983: Leigh P N; Reavill C; Jenner P; Marsden C D
Basal ganglia outflow pathways and circling behaviour in the rat.
Journal of neural transmission 1983;58(1-2):1-41.
1983: Jenner P; Sheehy M; Marsden C D
Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease.
British journal of clinical pharmacology 1983;15 Suppl 2():277S-289S.
1983: Marsden C D
Neuromelanin and Parkinson's disease.
Journal of neural transmission. Supplementum 1983;19():121-41.
1983: Marsden C D; Merton P A; Morton H B
Direct electrical stimulation of corticospinal pathways through the intact scalp in human subjects.
Advances in neurology 1983;39():387-91.
1983: Marsden C D; Obeso J A; Rothwell J C
Clinical neurophysiology of muscle jerks: myoclonus, chorea, and tics.
Advances in neurology 1983;39():865-81.
1983: Marsden C D; Rothwell J C; Day B L
Long-latency automatic responses to muscle stretch in man: origin and function.
Advances in neurology 1983;39():509-39.
1983: Marsden C D; Meadows J C; Merton P A
"Muscular wisdom" that minimizes fatigue during prolonged effort in man: peak rates of motoneuron discharge and slowing of discharge during fatigue.
Advances in neurology 1983;39():169-211.
1983: Jenner P; Kerwin R; Rupniak N M; Murugaiah K; Hall M D; Fleminger S; Marsden C D
Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
Journal of neural transmission. Supplementum 1983;18():205-12.
1983: Lang A E; Sheehy M P; Marsden C D
Acute anticholinergic action in focal dystonia.
Advances in neurology 1983;37():193-200.
1983: Rupniak N M; Jenner P; Marsden C D
Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats.
Psychopharmacology 1983;79(2-3):226-30.
1982: Marsden C D
Functions of the basal ganglia.
Rinsho shinkeigaku = Clinical neurology 1982;22(12):1093-4.
1982: Day B L; Marsden C D
Two strategies for learning a visually guided motor task.
Perceptual and motor skills 1982;55(3 Pt 1):1003-16.
1982: Lang A E; Ellis C; Kingon H; Marsden C D
Iris pigmentation in idiopathic dystonia.
Annals of neurology 1982;12(6):585-6.
1982: Margolin D I; Marsden C D
Episodic dyskinesias and transient cerebral ischemia.
Neurology 1982;32(12):1379-80.
1982: Quinn N P; Lang A E; Marsden C D
Insulin-induced hypoglycaemia does not abolish chorea.
Journal of neurology, neurosurgery, and psychiatry 1982;45(12):1169-70.
1982: Lang A E; Marsden C D
Alpha methylparatyrosine and tetrabenazine in movement disorders.
Clinical neuropharmacology 1982;5(4):375-87.
1982: Luscombe G; Jenner P; Marsden C D
Tryptamine-induced myoclonus in guinea-pigs pretreated with a monoamine oxidase inhibitor indicates pre- and post-synaptic actions of tryptamine upon central indoleamine systems.
Neuropharmacology 1982;21(12):1257-65.
1982: Burke R E; Fahn S; Jankovic J; Marsden C D; Lang A E; Gollomp S; Ilson J
Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs.
Neurology 1982;32(12):1335-46.
1982: Marsden C D
Basal ganglia disease.
Lancet 1982;2(8308):1141-7.
1982: Perry T L; Hansen S; Quinn N; Marsden C D
Concentrations of GABA and other amino acids in CSF from torsion dystonia patients.
Journal of neurochemistry 1982;39(4):1188-91.
1982: Marsden C D; Sheehy M P
Spastic dysphonia, Meige disease, and torsion dystonia.
Neurology 1982;32(10):1202-3.
1982: Quinn N P; Lang A E; Marsden C D
Insulin-induced hypoglycaemia does not abolish chorea.
Journal of neurology, neurosurgery, and psychiatry 1982;45(10):936-7.
1982: Fleminger S; Jenner P; Marsden C D
Are dopamine receptors present on human lymphocytes?
The Journal of pharmacy and pharmacology 1982;34(10):658-63.
1982: Marsden C D; Obeso J A; Lang A E
Adrenoleukomyeloneuropathy presenting as spinocerebellar degeneration.
Neurology 1982;32(9):1031-2.
1982: Lang A E; Marsden C D; Obeso J A; Parkes J D
Alcohol and Parkinson disease.
Annals of neurology 1982;12(3):254-6.
1982: Marsden C D; Merton P A; Morton H B
The latency of the anal reflex.
Journal of neurology, neurosurgery, and psychiatry 1982;45(9):857.
1982: Rothwell J C; Traub M M; Marsden C D
Automatic and "voluntary' responses compensating for disturbances of human thumb movements.
Brain research 1982;248(1):33-41.
1982: Sheehy M P; Marsden C D
Writers' cramp-a focal dystonia.
Brain : a journal of neurology 1982;105 (Pt 3)():461-80.
1982: Lang A E; Meadows J C; Parkes J D; Marsden C D
Early onset of the "on-off" phenomenon in children with symptomatic Parkinsonism.
Journal of neurology, neurosurgery, and psychiatry 1982;45(9):823-5.
1982: Lang A E; Quinn N; Brincat S; Marsden C D; Parkes J D
Pergolide in late-stage Parkinson disease.
Annals of neurology 1982;12(3):243-7.
1982: Rothwell J C; Traub M M; Day B L; Obeso J A; Thomas P K; Marsden C D
Manual motor performance in a deafferented man.
Brain : a journal of neurology 1982;105 (Pt 3)():515-42.
1982: Merton P A; Hill D K; Morton H B; Marsden C D
Scope of a technique for electrical stimulation of human brain, spinal cord, and muscle.
Lancet 1982;2(8298):597-600.
1982: Lang A E; Sheehy M P; Marsden C D
Anticholinergics in adult-onset focal dystonia.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1982;9(3):313-9.
1982: Quinn N; Marsden C D; Parkes J D
Complicated response fluctuations in Parkinson's disease: response to intravenous infusion of levodopa.
Lancet 1982;2(8295):412-5.
1982: Murugaiah K; Mann S; Theodorou A E; Jenner P; Marsden C D
Increased striatal acetylcholine after 14 months cis-flupenthixol treatment in rats suggests functional supersensitivity of dopamine receptors.
Life sciences 1982;31(2):181-8.
1982: Day B L; Marsden C D
Accurate repositioning of the human thumb against unpredictable dynamic loads is dependent upon peripheral feed-back.
The Journal of physiology 1982;327():393-407.
1982: Burke R E; Fahn S; Jankovic J; Marsden C D; Lang A E; Gollomp S; Ilson J
Tardive dystonia and inappropriate use of neuroleptic drugs.
Lancet 1982;1(8284):1299.
1982: Marsden C D
The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture.
Neurology 1982;32(5):514-39.
1982: Luscombe G; Jenner P; Marsden C D
Myoclonus in guniea pigs is induced by indole-containing but not piperazine-containing 5HT agonists.
Life sciences 1982;30(17):1487-94.
1982: Murugaiah K; Theodorou A; Mann S; Clow A; Jenner P; Marsden C D
Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatum.
Nature 1982;296(5857):570-2.
1982: Jenner P; Hall M D; Murugaiah K; Rupniak N; Theodorou A; Marsden C D
Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
Biochemical pharmacology 1982;31(3):325-8.
1982: Marsden C D
Motor disorders in schizophrenia.
Psychological medicine 1982;12(1):13-5.
1982: Marsden C D; Jefferson D; Leigh N; Jenner P
Plasma propranolol in essential tremor.
Annals of neurology 1982;11(1):107.
1982: Goebel H H; Braak H; Seidel D; Doshi R; Marsden C D; Gullotta F
Morphologic studies on adult neuronal-ceroid lipofuscinosis (NCL).
Clinical neuropathology 1982;1(4):151-62.
1982: Jenner P; Marsden C D
The mode of action of sulpiride as an atypical antidepressant agent.
Advances in biochemical psychopharmacology 1982;32():85-103.
1982: Marsden C D
Studies on the normal and disordered human motor cortex.
Electroencephalography and clinical neurophysiology. Supplement 1982;36():430-4.
1982: Obeso J A; Rothwell J C; Marsden C D
The neurophysiology of Tourette syndrome.
Advances in neurology 1982;35():105-14.
1982: Jenner P; Theodorou A; Marsden C D
Specific receptors for substituted benzamide drugs in brain.
Advances in biochemical psychopharmacology 1982;35():109-41.
1981: Marsden C D
What should neurologists do?
Journal of neurology, neurosurgery, and psychiatry 1981;44(12):1059-60.
1981: Taylor R J; Reavill C; Jenner P; Marsden C D
Circling behavior following unilateral kainic acid injections into rat striatum.
European journal of pharmacology 1981;76(2-3):211-22.
1981: Reavill C; Leigh P N; Jenner P; Marsden C D
Drug-induced circling after unilateral 6-hydroxydopamine lesions of the nigro-striatal pathway is mediated via the midbrain periaqueductal grey and adjacent reticular formation (angular complex).
Life sciences 1981;29(23):2357-65.
1981: Jenner P; Marsden C D
Substituted benzamide drugs as selective neuroleptic agents.
Neuropharmacology 1981;20(12B):1285-93.
1981: Jenner P; Rupniak N M; Hall M D; Dyer R; Leigh N; Marsden C D
Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment.
European journal of pharmacology 1981;76(1):31-6.
1981: Luscombe G; Jenner P; Marsden C D
Pharmacological analysis of the myoclonus induced by 5-hydroxytryptophan in the guinea pig suggests the presence of multiple 5-hydroxytryptamine receptors in the brain.
Neuropharmacology 1981;20(9):819-31.
1981: Marsden C D; Merton P A; Morton H B
Human postural responses.
Brain : a journal of neurology 1981;104(3):513-34.
1981: Rupniak N M; Jenner P; Marsden C D
The absence of sodium ions does not explain the failure of sulpiride to inhibit, in vitro, rat striatal dopamine-sensitive adenylate cyclase.
The Journal of pharmacy and pharmacology 1981;33(9):602-3.
1981: Barbeau A; Duvoisin R C; Gerstenbrand F; Lakke J P; Marsden C D; Stern G
Classification of extrapyramidal disorders. Proposal for an international classification and glossary of terms.
Journal of the neurological sciences 1981;51(2):311-27.
1981: Hallett M; Bielawski M; Marsden C D
Behavior of the long-latency stretch reflex prior to voluntary movement.
Brain research 1981;219(1):178-85.
1981: Obeso J A; Rothwell J C; Marsden C D
Simple tics in Gilles de la Tourette's syndrome are not prefaced by a normal premovement EEG potential.
Journal of neurology, neurosurgery, and psychiatry 1981;44(8):735-8.
1981: Marsden C D; Merton P A; Morton H B; Rothwell J C; Traub M M
Reliability and efficacy of the long-latency stretch reflex in the human thumb.
The Journal of physiology 1981;316():47-60.
1981: Theodorou A; Reavill C; Jenner P; Marsden C D
Kainic acid lesions of striatum and decortication reduce specific [3H]sulpiride binding in rats, so D-2 receptors exist post-synaptically on corticostriate afferents and striatal neurons.
The Journal of pharmacy and pharmacology 1981;33(7):439-44.
1981: Leigh P N; Marsden C D; Twomey A; Jefferson D
beta-Adrenoceptor antagonists and essential tremor.
Lancet 1981;1(8229):1106.
1981: Theodorou A; Gommeren W; Clow A; Leysen J; Jenner P; Marsden C D
Chronic neuroleptic treatment specifically alters the number of dopamine receptors in rat brain.
Life sciences 1981;28(14):1621-7.
1981: Kolbe H; Clow A; Jenner P; Marsden C D
Neuroleptic-induced acute dystonic reactions may be due to enhanced dopamine release on to supersensitive postsynaptic receptors.
Neurology 1981;31(4):434-9.
1981: Marsden C D
Dopamine hypothesis in acute psychosis.
The British journal of psychiatry : the journal of mental science 1981;138():269-70.
1981: Reavill C; Jenner P; Leigh N; Marsden C D
The role of nigral projections to the thalamus in drug-induced circling behaviour in the rat.
Life sciences 1981;28(13):1457-66.
1981: Marsden C D; Schachter M
Assessment of extrapyramidal disorders.
British journal of clinical pharmacology 1981;11(2):129-51.
1981: Parkes J D; Schachter M; Marsden C D; Smith B; Wilson A
Lisuride in parkinsonism.
Annals of neurology 1981;9(1):48-52.
1981: Mehta A B; Marsden C D
Latent idiopathic torsion dystonia provoked by thyrotoxicosis.
Journal of neurology, neurosurgery, and psychiatry 1981;44(1):93-4.
1981: Dyer R G; Murugaiah K; Theodorou A; Clow A; Jenner P; Marsden C D
During one year's neuroleptic treatment in rats striatal dopamine receptor blockade decreases but serum prolactin levels remain elevated.
Life sciences 1981;28(2):167-74.
1981: Reavill C; Leigh N; Jenner P; Marsden C D
Critical role of midbrain reticular formation in the expression of dopamine-mediated circling behaviour.
Advances in biochemical psychopharmacology 1981;30():187-204.
1981: Marsden C D; Sheehy M P
GABA and movement disorders.
Advances in biochemical psychopharmacology 1981;30():225-34.
1980: Schachter M; Sheehy M P; Parkes J D; Marsden C D
Lisuride in the treatment of Parkinsonism.
Acta neurologica Scandinavica 1980;62(6):382-5.
1980: Traub M M; Rothwell J C; Marsden C D
A grab reflex in the human hand.
Brain : a journal of neurology 1980;103(4):869-84.
1980: Leigh P N; Rothwell J C; Traub M; Marsden C D
A patient with reflex myoclonus and muscle rigidity: "jerking stiff-man syndrome".
Journal of neurology, neurosurgery, and psychiatry 1980;43(12):1125-31.
1980: Schachter M; Marsden C D; Parkes J D; Jenner P; Testa B
Deprenyl in the management of response fluctuations in patients with Parkinson's disease on levodopa.
Journal of neurology, neurosurgery, and psychiatry 1980;43(11):1016-21.
1980: Marsden C D
Managing extrapyramidal disorders.
British medical journal 1980;281(6244):871.
1980: Reavill C; Leigh N; Jenner P; Marsden C D
GABA mediated circling from substantia nigra.
Nature 1980;287(5780):368.
1980: MacKay A V; Sheppard G P; Saha B K; Motley B; Johnson A L; Marsden C D
Failure of lithium treatment in established tardive dyskinesia.
Psychological medicine 1980;10(3):583-7.
1980: Rothwell J C; Traub M M; Marsden C D
Influence of voluntary intent on the human long-latency stretch reflex.
Nature 1980;286(5772):496-8.
1980: Schachter M; Bédard P; Debono A G; Jenner P; Marsden C D; Price P; Parkes J D; Keenan J; Smith B; Rosenthaler J; Horowski R; Dorow R
The role of D-1 and D-2 receptors.
Nature 1980;286(5769):157-9.
1980: Chadwick D; Hallett M; Jenner P; Marsden C D
Observations on chloralose-induced myoclonus in guinea-pigs.
British journal of pharmacology 1980;69(3):535-40.
1980: Traub M M; Rothwell J C; Marsden C D
Anticipatory postural reflexes in Parkinson's disease and other akinetic-rigid syndromes and in cerebellar ataxia.
Brain : a journal of neurology 1980;103(2):393-412.
1980: Guiloff R J; George R J; Marsden C D
Reversible supranuclear ophthalmoplegia associated with Parkinsonism.
Journal of neurology, neurosurgery, and psychiatry 1980;43(6):552-4.
1980: Theodorou A E; Hall M D; Jenner P; Marsden C D
Cation regulation differentiates specific binding of [3H]sulpiride and [3H]spiperone to rat striatal preparations.
The Journal of pharmacy and pharmacology 1980;32(6):441-4.
1980: Jenner P; Marsden C D; Thanki C M
Behavioural changes induced by N,N-dimethyl-tryptamine in rodents.
British journal of pharmacology 1980;69(1):69-80.
1980: Clow A; Theodorou A; Jenner P; Marsden C D
Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
European journal of pharmacology 1980;63(2-3):145-57.
1980: Clow A; Theodorou A; Jenner P; Marsden C D
Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic administration.
European journal of pharmacology 1980;63(2-3):135-44.
1980: Marsden C D; Duvoisin R
Scoliosis and Parkinson's disease.
Archives of neurology 1980;37(4):253-4.
1980: Sheehy M P; Marsden C D
Trauma and pain in spasmodic torticollis.
Lancet 1980;1(8171):777-8.
1980: Reavill C; Jenner P; Marsden C D
Metabolite involvement in bromocriptine-induced circling behaviour in rodents.
The Journal of pharmacy and pharmacology 1980;32(4):278-84.
1980: Marsden C D; Jenner P
The pathophysiology of extrapyramidal side-effects of neuroleptic drugs.
Psychological medicine 1980;10(1):55-72.
1980: Jefferson D; Marsden C D
Metoprolol in essential tremor.
Lancet 1980;1(8165):427.
1980: Clow A; Jenner P; Marsden C D; Theodorou A
Regional changes in brain dopamine receptor function during six months trifluoperazine administration to rats [proceedings]
British journal of pharmacology 1980;68(1):163P-164P.
1980: Jenner P; Clow A; Reavill C; Theodorou A; Marsden C D
Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanisms.
The Journal of pharmacy and pharmacology 1980;32(1):39-44.
1980: Clow A; Theodorou A; Jenner P; Marsden C D
Changes in cerebral dopamine function induced by a year's administration of trifluoperazine or thioridazine and their subsequent withdrawal.
Advances in biochemical psychopharmacology 1980;24():335-40.
1980: Clow A; Theodorou A; Jenner P; Marsden C D
A comparison of striatal and mesolimbic dopamine function in the rat during 6-month trifluoperazine administration.
Psychopharmacology 1980;69(3):227-33.
1980: Clow A; Jenner P; Theodorou A; Marsden C D
Changes in cerebral dopamine metabolism and receptors during one-year neuroleptic administration and subsequent withdrawal: relevance to brain biochemistry in schizophrenia.
Advances in biochemical psychopharmacology 1980;24():53-5.
1979: Rothwell J C; Traub M M; Marsden C D
Primary writing tremor.
Journal of neurology, neurosurgery, and psychiatry 1979;42(12):1106-14.
1979: Jenner P; Leigh N; Marsden C D; Reavill C
Dopamine mediated circling behaviour is modulated by lesions of the ventromedial nucleus of the thalamus [proceedings]
British journal of pharmacology 1979;67(3):432P.
1979: Marsden C D; Rothwell J C; Traub M
The relationship between early automatic and late voluntary compensatory responses to muscle stretch in the long flexor of the human thumb [proceedings]
The Journal of physiology 1979;296():111P-112P.
1979: Clow A; Jenner P; Marsden C D; Reavill C; Theodorou A
Stereoselective blockade of cerebral dopamine receptors by sulpiride and sultopride [proceedings]
British journal of pharmacology 1979;67(3):433P.
1979: Schachter M; Blackstock J; Dick J P; George R J; Marsden C D; Parkes J D
Lisuride in Parkinson's disease.
Lancet 1979;2(8152):1129.
1979: Jenner P; Marsden C D; Pratt J; Reynolds E H
Modulation of picrotoxin-induced forepaw myoclonus in the rat by benzodiazepines [proceedings]
British journal of pharmacology 1979;67(3):440P.
1979: Jefferson D; Jenner P; Marsden C D
beta-Adrenoreceptor antagonists in essential tremor.
Journal of neurology, neurosurgery, and psychiatry 1979;42(10):904-9.
1979: Price P; Baxter R C; Parkes J D; Marsden C D
Opiate antagonists and Parkinson's disease.
Archives of neurology 1979;36(10):661.
1979: Reavill C; Leigh N; Jenner P; Marsden C D
Dopamine-mediated circling behaviour does not involve the nigro-tectal pathway.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1979;37(2):309-16.
1979: Pratt J; Jenner P; Reynolds E H; Marsden C D
Clonazepam induces decreased serotoninergic activity in the mouse brain.
Neuropharmacology 1979;18(10):791-9.
1979: Jenner P; Marsden C D
Tardive dyskinesias.
Lancet 1979;2(8148):900.
1979: Hallett M; Marsden C D
Ballistic flexion movements of the human thumb.
The Journal of physiology 1979;294():33-50.
1979: Marsden C D; Rothwell J C; Traub M M
Effect of thumb anaesthesia on weight perception, muscle activity and the stretch reflex in man.
The Journal of physiology 1979;294():303-15.
1979: Jefferson D; Jenner P; Marsden C D
Relationship between plasma propranolol concentration and relief of essential tremor.
Journal of neurology, neurosurgery, and psychiatry 1979;42(9):831-7.
1979: Hallett M; Chadwick D; Marsden C D
Cortical reflex myoclonus.
Neurology 1979;29(8):1107-25.
1979: Marsden C D; Rothwell J C; Traub M
Long latency stretch reflex of the human thumb can be reversed if the task is changed [proceedings]
The Journal of physiology 1979;293():41P-42P.
1979: Jenner P; Marsden C D
The substituted benzamides--a novel class of dopamine antagonists.
Life sciences 1979;25(6):479-85.
1979: Clow A; Jenner P; Marsden C D
Changes in dopamine-mediated behaviour during one year's neuroleptic administration.
European journal of pharmacology 1979;57(4):365-75.
1979: Jenner P; Leigh N; Marsden C D; Reavill C
Superior colliculus lesions do not alter dopamine mediated circling behaviour [proceedings]
British journal of pharmacology 1979;66(3):479P-480P.
1979: Clow A; Jenner P; Marsden C D; Pratt J; Reavill C; Thanki C; Theodorou A
Central properties of alpha-allophanyl-alpha-allyl-gamma-valerolactone (valofan) [proceedings]
British journal of pharmacology 1979;66(3):478P-479P.
1979: Marsden C D; Merton P A; Morton H B
Sensitivity, efficacy and disappearance of servo action in human muscle [proceedings]
The Journal of physiology 1979;292():56P.
1979: Chadwick D; Jenner P; Marsden C D
5-Hydroxytryptamine and myoclonus induced by 1,2-di-hydroxybenzene (catechol) in the guinea-pig.
British journal of pharmacology 1979;66(3):358-60.
1979: Theodorou A; Crockett M; Jenner P; Marsden C D
Specific binding of [3H]sulpiride to rat striatal preparations.
The Journal of pharmacy and pharmacology 1979;31(6):424-6.
1979: Jenner P; Marsden C D; Reavill C
Evidence for metabolite involvement in bromocryptine-induced circling behaviour [proceedings]
British journal of pharmacology 1979;66(1):103P-104P.
1979: Reavill C; Jenner P; Leigh N; Marsden C D
Turning behaviour induced by injection of muscimol or picrotoxin into the substantia nigra demonstrates dual GABA components.
Neuroscience letters 1979;12(2-3):323-8.
1979: Barette J; Marsden C D
Attitudes of families to some aspects of Huntington's chorea.
Psychological medicine 1979;9(2):327-36.
1979: Luscombe G; Clow A; Jenner P; Marsden C D
Antagonism by propranolol of central dopamine receptor stimulation is not related to beta-adrenergic blockade.
The Journal of pharmacy and pharmacology 1979;31(5):355-6.
1979: Jefferson D; Jenner P; Marsden C D
Relationship between plasma propranolol levels and the clinical suppression of essential tremor [proceedings]
British journal of clinical pharmacology 1979;7(4):419P-420P.
1979: Clow A; Jenner P; Theodorou A; Marsden C D
Neuroleptic drugs and the dopamine hypothesis.
Lancet 1979;1(8122):934.
1979: Clow A; Jenner P; Theodorou A; Marsden C D
Striatal dopamine receptors become supersensitive while rats are geven trifluoperazine for six months.
Nature 1979;278(5699):59-61.
1979: Harrison M J; Marsden C D; Jenner P
Effect of experimental ischemia on neurotransmitter amines in the gerbil brain.
Stroke; a journal of cerebral circulation 1979;10(2):165-8.
1979: Marsden C D
The emotion of pain and its chemistry.
Ciba Foundation symposium 1979;(69):305-13.
1978: Kataria M; Traub M; Marsden C D
Extrapyramidal side-effects of metoclopramide.
Lancet 1978;2(8102):1254-5.
1978: Elliott P N; Jenner P; Marsden C D
Atropine manipulation of elevated cerebral dopamine turnover caused by haloperidol or substituted benzamide drugs.
The Journal of pharmacy and pharmacology 1978;30(12):788-91.
1978: Jenner P; Marsden C D; Pratt J; Reynolds E H
Altered serotoninergic activity in mouse brain induced by clonazepam [proceedings]
British journal of pharmacology 1978;64(3):432P.
1978: Clow A; Jenner P; Marsden C D
Supersensitivity of cerebral dopamine receptors during on-going chronic (six months) administration of trifluoperazine to rats [proceedings]
British journal of pharmacology 1978;64(3):414P.
1978: Price P; Parkes J D; Marsden C D
Tiapride in Parkinson's disease.
Lancet 1978;2(8099):1106.
1978: Price P; Debono A; Parkes J D; Marsden C D; Rosenthaler J
Plasma bromocriptine levels, clinical and growth hormone responses in Parkinsonism.
British journal of clinical pharmacology 1978;6(4):303-9.
1978: Dolphin A; Jenner P; Marsden C D
3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the rat.
The Journal of pharmacy and pharmacology 1978;30(9):580-2.
1978: Jenner P; Clow A; Reavill C; Theodorou A; Marsden C D
A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs.
Life sciences 1978;23(6):545-9.
1978: Clow A; Jenner P; Marsden C D
An experimental model of tardive dyskinesias.
Life sciences 1978;23(5):421-3.
1978: Price P A; Parkes J D; Marsden C D
Sodium valproate in the treatment of levodopa-induced dyskinesia.
Journal of neurology, neurosurgery, and psychiatry 1978;41(8):702-6.
1978: Marsden C D; Rothwell J C; Traub M M
Changes in perceived heaviness in man after thumb anaesthesia are associated with corresponding changes in the degree of muscle activation [proceedings]
The Journal of physiology 1978;280():66P-67P.
1978: Jenner P; Pycock C; Marsden C D
The effect of chronic administration and withdrawal of amphetamine on cerebral dopamine receptor sensitivity.
Psychopharmacology 1978;58(2):131-6.
1978: Horton R W; Jenner P; Marsden C D; Meldrum B S; Reavill C
Behavioural effects of allylglycine (2-amino-4-pentenoic acid) and 2-keto-4-pentenoic acid following focal injection into the rat cerebellum and caudate nucleus [proceedings]
British journal of pharmacology 1978;63(2):381P.
1978: Jenner P; Marsden C D; Thanki C M
Behavioural changes induced by N,N-dimethyltryptamine in rodents [proceedings]
British journal of pharmacology 1978;63(2):380P.
1978: Bédard P; Parkes J D; Marsden C D
Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias.
British medical journal 1978;1(6118):954-6.
1978: Tarsy D; Pycock C J; Meldrum B S; Marsden C D
Focal contralateral myoclonus produced by inhibition of GABA action in the caudate nucleus of rats.
Brain : a journal of neurology 1978;101(1):143-62.
1978: Pycock C; Milson J; Tarsy D; Marsden C D
The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system.
Neuropharmacology 1978;17(3):175-83.
1978: Marsden C D; Merton P A; Morton H B
Anticipatory postural responses in the human subject [proceedings]
The Journal of physiology 1978;275():47P-48P.
1978: Chadwick D; Gorrod J W; Jenner P; Marsden C D; Reynolds E H
Functional changes in cerebral 5-hydroxytryptamine metabolism in the mouse induced by anticonvulsant drugs.
British journal of pharmacology 1978;62(1):115-24.
1978: Pycock C J; Marsden C D
The rotating rodent: a two component system?
European journal of pharmacology 1978;47(2):167-75.
1978: Chadwick D; Hallett M; Jenner P; Marsden C D
5-hydroxytryptophan-induced myoclonus in guinea pigs. A physiological and pharmacological investigations.
Journal of the neurological sciences 1978;35(1):157-65.
1978: Jenner P; Elliott P N; Clow A; Reavill C; Marsden C D
A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs.
The Journal of pharmacy and pharmacology 1978;30(1):46-8.
1978: Marsden C D; Merton P A; Morton H B; Adam J E
Feedback control of voluntary movements in man.
Electroencephalography and clinical neurophysiology. Supplement 1978;(34):507-10.
1977: Donaldson I M; Dolphin A C; Jenner P; Pycock C; Marsden C D
Rotational behaviour produced in rats by unilateral electrolytic lesions of the ascending noradrenergic bundles.
Brain research 1977;138(3):487-509.
1977: Dolphin A C; Jenner P; Sawaya M C; Marsden C D; Testa B
The effect of bromocriptine on locomotor activity and cerebral catecholamines in rodents.
The Journal of pharmacy and pharmacology 1977;29(12):727-34.
1977: Jenner P; Marsden C D; Pycock C; Reavill C
Lack of serotoninergic involvement in turning behaviour induced by a unilateral lesion of the locus coeruleus in rats [proceedings]
British journal of pharmacology 1977;61(3):482P.
1977: Sawaya M C; Dolphin A; Jenner P; Marsden C D; Meldrum B S
Noradrenaline-sensitive adenylate cyclase in slices of mouse limbic forebrain: characterisation and effect of dopaminergic agonists.
Biochemical pharmacology 1977;26(20):1877-84.
1977: Jenner P; Marsden C D; Pycock C J
Chronic amphetamine administration and central dopamine receptor sensitivity [proceedings]
British journal of pharmacology 1977;61(1):142P.
1977: Dolphin A; Christina M; Sawaya M C; Jenner P; Marsden C D
Behavioural and biochemical effects of chronic reduction of cerebral noradrenaline receptor stimulation.
Naunyn-Schmiedeberg's archives of pharmacology 1977;299(2):167-73.
1977: Marsden C D; Merton P A; Morton H B; Adam J
The effect of lesions of the sensorimotor cortex and the capsular pathways on servo responses from the human long thumb flexor.
Brain : a journal of neurology 1977;100(3):503-26.
1977: Chadwick D; Hallett M; Harris R; Jenner P; Reynolds E H; Marsden C D
Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
Brain : a journal of neurology 1977;100(3):455-87.
1977: Hallett M; Chadwick D; Marsden C D
Ballistic movement overflow myoclonus a form of essential myoclonus.
Brain : a journal of neurology 1977;100(2):299-312.
1977: Clow A; Elliott P N; Jenner P; Marsden C D; Pycock C
Interactions of substituted benzamide drugs with cerebral dopamine pathways [proceedings]
British journal of pharmacology 1977;60(2):268P-269P.
1977: Meldrum B S; Anlezark G M; Marsden C D
Acute dystonia as an idiosyncratic response to neuroleptics in baboons.
Brain : a journal of neurology 1977;100(2):313-26.
1977: Chadwick D; Hallet M; Jenner P; Marsden C D
5-Hydroxytryptophan-induced behaviour in guinea-pigs: its relevance to human myoclonus [proceedings]
British journal of clinical pharmacology 1977;4(3):402P-403P.
1977: Elliott P N; Jenner P; Huizing G; Marsden C D; Miller R
Substituted benzamides as cerebral dopamine antagonists in rodents.
Neuropharmacology 1977;16(5):333-42.
1977: Parkers J D; Marsden C D; Price P
Amantadine-induced heart-failure.
Lancet 1977;1(8017):904.
1977: Marsden C D; Merton P A; Morton H B; Adam J
The effect of posterior column lesions on servo responses from the human long thumb flexor.
Brain : a journal of neurology 1977;100 Pt 1():185-200.
1977: Dolphin A C; Jenner P; Marsden C D; Sawaya M C
Central dopaminergic and noradrenergic components of bromocryptine-induced locomotor activity in mice [proceedings].
British journal of pharmacology 1977;59(3):467P.
1977: Pycock C J; Jenner P G; Marsden C D
The interaction of clonidine with dopamine-dependent behaviour in rodents.
Naunyn-Schmiedeberg's archives of pharmacology 1977;297(2):133-41.
1977: Hallett M; Chadwick D; Adam J; Marsden C D
Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus.
Journal of neurology, neurosurgery, and psychiatry 1977;40(3):253-64.
1977: Castall B; Marsden C D; Naylor R J; Pycock C J
Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
Brain research 1977;123(1):89-111.
1977: Galea-Debono A; Jenner P; Marsden C D; Parkes J D; Tarsy D; Walters J
Plasma DOPA levels and growth hormone response to levodopa in parkinsomism.
Journal of neurology, neurosurgery, and psychiatry 1977;40(2):162-7.
1977: Marsden C D; Merton P A; Morton H B
The sensory mechanism of servo action in human muscle.
The Journal of physiology 1977;265(2):521-35.
1977: Marsden C D; Parkes J D
Success and problems of long-term levodopa therapy in Parkinson's disease.
Lancet 1977;1(8007):345-9.
1977: Pycock C J; Marsden C D
Central deopaminergic receptor supersensitivity and its relevance to Parkinson's disease.
Journal of the neurological sciences 1977;31(1):113-21.
1977: Elliott P N; Jenner P; Chadwick D; Reynolds E; Marsden C D
The effect of diphenylhydantoin on central catecholamine containing neuronal systems.
The Journal of pharmacy and pharmacology 1977;29(1):41-3.
1977: Bedard P; Parkes J D; Marsden C D
Nomifensine in Parkinson's disease.
British journal of clinical pharmacology 1977;4Suppl 2():187S-190S.
1976: Marsden C D; Merton P A; Morton H B
Servo action in human posture [proceedings]
The Journal of physiology 1976;263(1):187P-188P.
1976: Chadwick D; Reynolds E H; Marsden C D
Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics.
Journal of neurology, neurosurgery, and psychiatry 1976;39(12):1210-8.
1976: Marsden C D
Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia?
Journal of neurology, neurosurgery, and psychiatry 1976;39(12):1204-9.
1976: Costall B; Marsden C D; Naylor R J; Pycock C J
The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
Brain research 1976;118(1):87-113.
1976: Parkes J D; Debono A G; Marsden C D
Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
Journal of neurology, neurosurgery, and psychiatry 1976;39(11):1101-8.